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 ABSTRACT OF DISSERTATION 
 
 
 
ROLE  OF  ARYL  HYDROCARBON  RECEPTOR 
IN 
CHRONIC  INFLAMMATORY  DISEASES 
 
 
 
 
 
        Aryl Hydrocarbon Receptor (AhR) is a ligand-activated receptor known as the 
dioxin receptor. Environment al pollutants called dioxin - like toxicants are found in 
food, cigarette smoke, automobile exhaust and air. Therefore, they could chronically 
amplify the pathology  of numerous chronic inflammatory diseases. AhR is a well-
known target of these environmental chemicals that disrupt endocrine signaling. By 
the year 2020, the number of people older than 60 years is expected to top 1 billion. 
The burden of treating chronic disease is significant both in dollars spent and in lost 
productivity. The need to identify risk factors for chronic diseases must be evaluated 
along with diet and lifestyle factors that will promote healthy aging. 
         The studies presented in this dissertation tested the hypothesis that habitual 
exposure to dioxin-like contaminants contributes to chronic inflammatory disease 
states through activation of AhR pathway. Due to  their lipophilicity, dioxin like 
toxicants (like PCB 77) accumulated in mice' visceral adipose tissue and induced 
adipocytes maturation and ectopic fat deposition. Exposure to persistent organic  
pollutants, such as  polychlorinated biphenyls (PCB 77) can cause endothelial cells  
activation and inflammation by inducing pro-inflammatory signaling pathways. In our 
studies, PCB 77 had cumulative effects in Angiotensin II - induced Abdominal Aortic 
Aneurysm (AAA) by exacerbating inflammation in and around the aortic wall. More,
PCB 77 increased mortality in mice that developed AAA. 
         In order to appreciate the AhR involvement in inflammation we used a mouse 
model of Inflammatory Bowel Disease (IBD). Mice that had a reduced AhR receptor 
expression developed a less severe colitis and had a decreased general 
inflammatory status. 
        These data provide evidence that exposure to  environmental toxicants could 
augment inflammation and contribute to the social burden of obesity and obesity-
related chronic inflammatory diseases. 
KEYWORDS: Dioxin and dioxin-like environmental pollutants, Obesity, 
Atherosclerosis, Abdominal Aortic Aneurysm, Inflammatory Bowel Diseases  
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Chapter One 
Introduction 
 
          Chronic inflammatory diseases (CID) afflict millions of people across the 
world leading to suffering, economic loss and premature death.  The rapid increase 
in the number of people with CID is now attributed to intricate cross talk between 
genetic make-up and environmental factors such as metals, persistent and non-
persistent pesticides, dioxins and furans, polychlorinated biphenyls (PCBs), 
phthalates, and environmental tobacco smoke.  
          Polychlorinated biphenyls (PCBs) are persistent environmental contaminants 
that have been associated with a wide spectrum of adverse health effects. Although 
manufacture of PCBs in the US was banned in 1977 they are still present in the 
environment [1] [2] and are biodistributed  throughout the food chain, leading to 
habitual human exposure. There are more than 500 Superfund sites in Kentucky 
alone, where the rates of such chronic diseases as cardiovascular disease, cancer, 
diabetes, and hypertension are well above national averages 
The dioxin-like PCBs are the most toxic environmental pollutants and act 
through the aryl hydrocarbon receptor (AhR). It is a ligand activated transcription 
factor with important roles in xenobiotic metabolism, developmental and normal 
physiology. Many ligands have been identified for this intracellular receptor, 
however, there is none to be considered as a relevant endogenous agonist. Upon 
activation, AhR translocates to nucleus and binds to xenobiotic response elements 
(XREs).  These elements are found in the 5' upstream region of genes involved not 
only in cell proliferation and differentiation [3]  or protection against oxidative stress 
(Nrf2) but also in inflammation[4],  activation of NF-kB [5] and regulatory T cells 
(Treg) regulation [6]. 
Inflammation is a vital defense mechanism of the body against infection, 
tissue injury or cellular stress. Phagocytic cells, like macrophages, are the first line 
of defense and by secreting inflammatory cytokines, they eliminate the pathogens. 
When the injury is too extensive or the instigator is a persistent toxicant with a very 
long half-life, the balance tips toward the pro-inflammatory status and the damages 
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lead to chronicity. 
Accordingly, we have set our objectives to address the question of how 
background exposure to environmental dioxin-like toxicants affect morbidity and 
mortality of modern day chronic diseases like obesity, diabetes, atherosclerosis and 
metabolic syndrome. Due to their high lipophilicity, we expected a higher 
accumulation in the adipose tissue that will parallel the epidemic of obesity. 
Recently, the adipose tissue has been recognizing as a very active endocrine organ 
during diabetes and metabolic syndrome. Therefore, a higher exposure to dioxin 
like compounds will be associated with an increase in the diabetogenic and 
metabolic risk. 
On the other hand, it has been repeatedly confirmed that obese individuals 
have a higher serum concentration of angiotensinogen, renin, aldosterone and 
angiotensin converting enzyme (ACE) [7-9]. Furthermore, visceral adipose tissue 
generates more angiotensinogen than other fat depots[10] and places obese people 
at risk for hypertension, atherosclerosis, abdominal aortic aneurysm (AAA), 
diabetes and non alcoholic fatty liver disease (NAFLD). Correlations between 
hypertension and cigarette smoking and the development of AAA were found in 
many studies and give us a glimpse on the interplay between environmental factors 
and genetic risk. Nowadays, due to an increase in the technical possibility to 
analyze cigarette smoke composition we just found out that dioxin-like residues are 
habitual constituents of cigarette tar[11]. 
Thus, the accumulation and action of dioxin-like toxicants in adipose tissue 
may prove to participate in the pathophysiology of obesity-associated chronic 
inflammatory diseases.    
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Chapter Two   
Polychlorinated Biphenyl -77 induces adipocytes differentiation and 
proinflammatory adipokines and promotes obesity and atherosclerosis 
 
Synopsis 
Background.  Obesity, an inflammatory condition linked to cardiovascular 
disease, is associated with expansion of adipose tissue. Highly prevalent coplanar 
polychlorinated biphenyls (PCBs) such as 3, 3′,4,4′-tetrachlorobiphenyl (PCB-77) 
accumulate in adipose tissue because of their lipophilicity and increase in adipose 
tissue with obesity. However, the effects of PCBs on adipocytes, obesity, and 
obesity-associated cardiovascular disease are unknown. 
Objectives.  In this study, we examined in vitro and in vivo effects of PCB-77 
on adipocyte differentiation, proinflammatory adipokines, adipocyte morphology, 
body weight, serum lipids, and atherosclerosis. 
Methods. PCB-77 or 2, 2′, 4, 4, 5, 5′-hexachlorobiphenyl (PCB-153) was 
incubated with 3T3-L1 adipocytes either during differentiation or in mature 
adipocytes. Concentration-dependent effects of PCB-77 were contrasted with those 
of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). For in vivo studies, we treated 
C57BL/6 wild-type (WT) or aryl hydrocarbon receptor (AhR) −/− mice with vehicle or 
PCB-77 (49 mg/kg, by intraperitoneal injection) and examined body weight gain. In 
separate studies, we injected ApoE−/− mice with vehicle or PCB-77 over a 6-week 
period and examined body weight, adipocyte size, serum lipids, and 
atherosclerosis. 
Results. Low concentrations of PCB-77 or TCDD increased adipocyte 
differentiation, glycerol–3-phosphate dehydrogenase activity, and expression of 
peroxisome proliferator–activated receptor γ, whereas higher concentrations 
inhibited adipocyte differentiation. Effects of PCB-77 were abolished by the AhR 
antagonist α-naphthoflavone. PCB-77 promoted the expression and release of 
various proinflammatory cytokines from 3T3-L1 adipocytes. Administration of PCB-
77 increased body weight gain in WT but not AhR−/− mice. ApoE−/− mice injected 
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with PCB-77 exhibited greater body weight, adipocyte hypertrophy, serum 
dyslipidemia, and augmented atherosclerosis. 
Conclusions. Our findings suggest that PCB-77 may contribute to the 
development of obesity and obesity-associated atherosclerosis. 
 
Introduction 
Polychlorinated biphenyls (PCBs), industrial chemicals that were produced 
and sold in the United States for approximately 50 years[12], have continued to bio-
accumulate throughout the ecosystem. PCBs are highly lipophilic, with octanol: 
water partition coefficients of ≥ 104 and, as such, accumulate markedly in lipid-rich 
tissues [13]. In lean people, white adipose tissue makes up approximately 15–25% 
of body weight, and this amount is increased by > 50% in cases of morbid 
obesity[14]. Thus, the capacity of adipose tissue to accumulate lipophilic PCBs is 
considerable and would be anticipated to increase with obesity. 
The prevalence of obesity has increased at an alarming rate, with 65.4% of 
the adult population in the United States overweight and 30.5% of adults exhibiting 
obesity [15]. Even more alarming, the prevalence of overweight children in the age 
range of 6–11 years increased from 4.2% in 1963 to 15.3% in 1999–2000[15].  
Reaven et al.,[16]  noted that several risk factors for cardiovascular disease cluster 
around an obesity phenotype, termed the metabolic syndrome. Cardiovascular 
disease has been identified as a primary clinical outcome of patients diagnosed with 
the metabolic syndrome[17].  Of the cardiovascular diseases associated with 
obesity, atherosclerosis is a primary cause of death in obese patients[17]. Thus, it is 
important to define mechanisms contributing to the development of obesity and that 
link obesity to cardiovascular disease. 
Interesting recent findings suggest that in nondiabetics with the metabolic 
syndrome, PCBs were linearly associated with waist circumference[18]. Because 
serum concentrations of PCBs show decreasing trends but obesity is at epidemic 
proportions, the authors suggested that the toxicity of PCBs may synergistically 
increase as people become obese [18]. Despite the potential for adipocytes to be 
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frequently exposed to PCBs, the specific effects of PCBs on adipocyte function 
have not been defined. Moreover, the impact of enhanced PCB sequestration in the 
expanded adipose mass with obesity on the development of obesity-associated 
cardiovascular diseases is unknown. 
Previous results demonstrated that coplanar 3, 3′, 4, 4′-tetrachlorobiphenyl 
(PCB-77), an aryl hydrocarbon receptor (AhR) ligand, promoted inflammation in 
endothelial cells [19-22]. Adipocytes express the AhR [23]; however, it is unclear 
whether coplanar PCBs will also induce expression of inflammatory cytokines in 
adipocytes. Induction of proinflammatory cytokines by PCBs in adipocytes would be 
anticipated to promote the development of obesity and obesity-associated 
cardiovascular disease[14]. In the present study, we contrasted the concentration-
dependent effects of coplanar PCB-77 versus 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin 
(TCDD) on adipocyte differentiation using 3T3-L1 adipocytes. Because PCB-77 has 
been demonstrated to induce inflammatory pathways in endothelial cells [19-22], we 
examined the effects of PCB-77 on proinflammatory and anti-inflammatory 
adipokine expression in 3T3-L1 adipocytes. To extend these in vitro findings, we 
defined the in vivo effects of PCB-77 on body weight gain in C57BL/6 and AhR−/− 
mice. In separate studies, to determine whether effects of PCB-77 would promote 
cardiovascular diseases linked to obesity, we defined the effects of PCB-77 on the 
development of obesity, alterations in serum lipids, and atherosclerosis in 
apolipoprotein E (apoE)−/− mice. 
 
Materials and Methods 
PCB-77, 2, 2′, 4, 4, 5, 5′-hexachlorobiphenyl (PCB-153), and TCDD were 
obtained from AccuStandard Inc. (New Haven, CT). α-Naphthoflavone (α-NF) was 
obtained from Sigma Aldrich (St. Louis, MO). 
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Cell culture and treatment  
3T3-L1 mouse embryo fibroblasts, purchased from American Type Culture 
Collection (Manassas, VA) were maintained in standard Dulbecco’s modified 
Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal 
bovine serum (FBS; Gemini Bio-Products, Woodland, CA) and 1% 
penicillin/streptomycin and subcultured in 60-mm cell culture dishes. Cultured cells 
(passage number 6 or lower) were allowed to grow to 100% confluence at 37°C in a 
humidified 5% CO2 atmosphere with media changes every 2–3 days. For each 
experimental parameter measured, assays were performed on duplicate wells of 
cells within an individual experiment, with a total of three to five experimental 
replicates. 
To define the effects of PCBs on adipocyte differentiation, we incubated 
preadipocytes with PCB-77 or PCB-153 (3.4 μM) (Hennig et al. 1999, 2002b) 1 day 
before the induction of differentiation through day 8 of differentiation. Differentiation 
was induced by incubating cells for 2 days with a cocktail containing insulin (0.1 μM; 
91Sigma, St. Louis, MO), dexamethasone (1 μM; Sigma), and 
isobutylmethylxanthine (0.5 mM, IBMX; Sigma). On the third day, the media was 
changed to contain only insulin for 1 day, followed by DMEM with 10% FBS for a 
total of 8 days. Cells were harvested for measurement of oil red O staining, 
glycerol–3-phosphate dehydrogenase (GPDH) activity, or mRNA quantification of 
gene expression. 
In separate experiments, to contrast concentration-dependent effects of 
PCB-77 to TCDD, we incubated preadipocytes with vehicle [0.03% 
dimethylsulfoxide (DMSO)], PCB-77 (3.4 or 68 μM), or TCDD (0.1, 1, or 10 nM) 
beginning on day −1 through day 8 of differentiation. Cells were harvested on day 8 
for measurement of oil red O staining. To define the role of the AhR in PCB-77− 
induced regulation of adipocyte differentiation, preadipocytes were incubated with 
20 μM α-NF for 30 min before the addition of vehicle, PCB-77 (3.4 μM), or TCDD 
(0.1 nM) on day 1 through day 8 of differentiation. Cells were harvested on day 8 for 
measurement of oil red O staining. 
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To define the effects of PCBs on mature adipocytes, preadipocytes were 
differentiated using the protocol described above and vehicle, PCB-77 (3.4 μM), or 
PCB-153 (3.4 μM) was added to the media on day 8 for 24 or 48 hr. Cells were then 
harvested for mRNA quantification of gene expression and oil red O staining. Cell 
media was assayed for cytokines as described below. 
 
Oil red O staining  
Cells were washed once with sterile phosphate-buffered saline (PBS) and 
fixed with 10% formaldehyde in PBS for 5 min at room temperature (Hanlon et al. 
2003). Oil red O (0.5% wt/vol stock solution; Sigma) mixed with water (60:40) was 
used to stain cells (3 mL for 30 min). Dye was extracted from cell culture dishes with 
isopropanol (1 mL), and the absorbance was measured spectrophotometrically at 
510 nm (Ramirez-Zacarias et al. 1992). 
 
GPDH activity  
Cells were rinsed with ice-cold PBS, scraped into 0.2 mL extraction buffer 
(GPDH assay kit; TAKARA Bio Inc., Shiga, Japan), and centrifuged for 10 min at 
40°C. GPDH activity was assayed in the supernatant by monitoring the decrease in 
absorbance at 340 nm of NADH in the presence of dihydroxyacetone phosphate 
(Wise and Green 1979). 
 
RNA isolation and gene expression analysis using real-time polymerase 
chain reaction (PCR)  
Total RNA was extracted from tissues or cells using the phenol guanidine-
isothiocyanate method (TRIZOL kit; Invitrogen) per the manufacturer’s instructions. 
Total RNA (0.4 μg) was reverse transcribed for 1 hr at 55°C with the following 
components: random decamers, 10× reverse transcription buffer, deoxynucleotide 
triphosphate mix, ribonuclease inhibitor, and reverse transcriptase (RETROscript; 
Ambion, Austin, TX). The reverse-transcribed cDNA obtained was then amplified 
using an iCycler (Bio-Rad, Hercules, CA) with the SYBR Green PCR core reagents 
kit (Applied Biosystems, Foster City, CA). The ingredients used for the PCR in a 
total reaction volume of 50 μL included SYBR Green mix (1×), MgCl2 (3 mM), dNTP 
 
7 
 
mix (1.25 mM), fluorescein (0.01 μM), primers (0.5 μM), and Amplitaq gold 
polymerase (2.5 units). Relative quantification of gene expression in the samples 
was then performed using the standard curve method, and a ratio to 18s rRNA 
(reference gene) was tabulated. The primers (Qiagen, Valencia, CA) were designed 
using Primer 3 software (SourceForge, Mountain View, CA), and the sequences are 
shown in Table 1. The PCR conditions were as follows: 94°C for 5 min, 40 cycles at 
94°C for 1 min, 64°C for 1 min, 72°C for 1 min, and a final elongation step of 72°C 
for 10 min. 
 
Measurement of PCBs in cells, plasma, and tissue  
For the separation of analytes, we used a fully automated Dionex ASE 200 
system (Dionex Corporation, Sunnyvale, CA) for assisted solvent extraction and gel 
permeation chromatography/mass spectrometry (Sipka et al. 2008). This system 
works by pumping a solvent (hexane) into the top of an electrochemical detection 
cell, which contains the sample and performs any in-cell cleanup options. The cell is 
brought to elevated pressure and temperature, and then the extract is forced out of 
the bottom of the cell and collected in a vial for additional cleanup if necessary. 
Detection was performed with two microelectron capture detectors; we used 
Chemstation software (Agilent, Palo Alto, CA) to run the system and interpret the 
chromatograms. An external standard mixture of PCBs, at known concentrations, 
was used to test for recovery of the extraction and quantification of PCBs. The limits 
of detection for PCBs were 0.1 ng/g of tissue (or 0.05 ppm), with coefficient of 
variability < 3.5% and accuracy (error < 1.5%). 
 
Measurement of adipokines in media from adipocytes  
We measured adipokines in the media of adipocytes using a Luminex multi-
analyte detection platform (Mouse Adipocyte Panel; Cayman, Ann Arbor, MI). 
Values are picograms per milliliter of cell culture media. 
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Animal treatments and sample collection  
Male C57BL/6 mice or AhR−/− mice (The Jackson Laboratory, Bar Harbor, 
ME) at 3 months of age (n = 10 mice/group) were housed in a pathogen-free 
environment. Mice were given free access to food and water. All procedures were 
approved by the Animal Care and Use Committee at the University of Kentucky. 
Mice were administered vehicle (safflower oil, 0.4 mL) or PCB-77 (49 mg/kg, 0.4 
mL) by intraperitoneal (i.p.) injection for a total of four injections (two in week 1, two 
in week 4) during the 6-week study duration. Body weight was measured weekly. In 
separate studies, 3-month-old male ApoE−/− mice bred in-house to C57BL/6 mice 
from stock originally purchased from The Jackson Laboratory (n = 10 mice/group) 
were administered vehicle (safflower oil, 0.4 mL i.p.) or PCB-77 (49 mg/kg, 0.4 mL 
i.p.) using the same experimental protocol (a total of four injections: two in week 1, 
two in week 4) during the 6-week study duration. At the study end, mice were 
anesthetized with ketamine/xylazine (100/10 mg/kg i.p.) for blood and tissue 
harvest. 
 
Serum cholesterol measurement  
We determined serum cholesterol concentrations and lipoprotein cholesterol 
distributions in ApoE−/− mice in each treatment group as described previously 
(Daugherty et al. 2000; Manning et al. 2003). 
 
Histology  
A portion of each tissue (mesenteric fat, liver) from ApoE−/− mice in each 
treatment group was fixed in 4% paraformaldehyde overnight, embedded in 
paraffin, and cut in serial sections (5 μm). Sections were deparaffinized and stained 
with hematoxylin and eosin. Adipocyte area was quantified in three sections for 
each mouse (three fields per section) using an Olympus BX51 microscope and 
Olympus U-CMAD3 digital camera (Olympus America, Center Valley, PA) and 
Image-Pro Plus 4.5 software (Media Cybernetics Inc., Bethesda, MD). 
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Quantification of atherosclerosis  
Frozen aortic root tissues from ApoE−/− mice in each treatment group were 
sectioned and discarded until the aortic sinus was reached. Tissue samples (10 μM) 
were subsequently sectioned and placed on slides (Probe-on Plus; Fisher Scientific, 
Pittsburgh, PA). From the start of section acquisition at the aortic sinus, each 
section was retained and sequentially placed on 8 slides. A total of 10 slides, each 
having approximately nine sections 90 μm apart covering approximately 720 μm of 
the root, were stained for lipid using oil red O. Using a Digital DXM camera (Nikon 
Instruments Inc., Melville, NY) mounted on a microscope, images (40×) were taken 
and the area of lesions quantified using Image-Pro Software Plus 4.5. 
 
Statistical analysis  
Data are expressed as mean + SE. Data were tested for normality and equal 
variance. For in vitro studies comparing effects of PCB-77 with PCB-153, data were 
analyzed using one-way analysis of variance (ANOVA) (GraphPad Prism, version 4; 
GraphPad Software Inc., San Diego, CA). For studies examining concentration 
dependence of PCB-77 or TCDD, data were analyzed by two-way ANOVA, with 
toxic compound and concentration as between-group factors. For post hoc analysis, 
data were analyzed using Tukey’s test, with significance at p < 0.05. For studies in 
C57BL/6 and AhR−/− mice, body weight gain was analyzed by one-way ANOVA with 
repeated measures on time. For studies in ApoE−/− mice, with the exception of body 
weight, data were analyzed by Student’s independent t-test. Significance was 
accepted at p < 0.05. 
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Results 
 
PCB-77 promotes 3T3-L1 adipocyte differentiation and the expression of 
proinflammatory adipokines  
We examined the effects of coplanar PCB-77 and nonplanar PCB-153 at 
equivalent concentrations (3.4 μM) [19, 20] on the differentiation of 3T3-L1 
adipocytes. PCB-77, but not PCB-153, increased oil red O staining (Figure 1A). 
Expression (mRNA) of peroxisome proliferator–activated receptor γ (PPARγ), a 
master regulator of adipocyte differentiation, and its downstream target, adipocyte 
fatty acid–binding protein (aP2), were increased by PCB-77, but not by PCB-153 
(Figure 1C). PCB-77 resulted in an increase in mRNA expression of 
angiotensinogen (Ao), tumor necrosis factor α (TNF-α), and differentiation-36 
(CD36) (Figure 1C). In contrast, adiponectin mRNA expression and concentrations 
in cell media (Table 2) were decreased by PCB-77. In addition, PCB-77 increased 
the concentrations of monocyte chemoattractant protein-1 (MCP-1) and 
keratinocyte chemoattractant-1 (KC-1) in cell media (Table 2). 
The ability of PCB-77 to promote adipokine expression when incubated with 
preadipocytes could result from enhanced adipocyte differentiation. We therefore 
examined the effect of PCB-77 and PCB-153 on mRNA abundance of adipokines 
when incubated with mature differentiated adipocytes (day 8) for 24 or 48 hr. The 
late-stage differentiation marker, GPDH activity, was increased by PCB-77 (Figure 
2A; 48-hr incubation). In addition, oil red O staining was increased by PCB-77 
(Figure 2A; 48-hr incubation). After 24 hr incubation, PCB-77 increased the mRNA 
expression of PPARγ, Ao, aP2, and CD36 (Figure 2B).  
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The concentration-dependent effects of PCB-77 versus TCDD and the role of the 
AhR  
PCB-77 has affinity for AhR; TCDD, a potent AhR ligand, has been shown to 
inhibit adipocyte differentiation at concentrations > 1 nM (Alexander et al. 1998). We 
therefore compared the concentration-dependent effects of PCB-77 (3.4, 34, and 68 
μM) with TCDD (0.1, 1, and 10 nM) on the differentiation of 3T3-L1 adipocytes. We 
chose PCB-77 concentrations based on a toxic equivalency factor (TEF; compares 
the relative potency of a compound with TCDD, assigned as 1.0 TEF) of 0.0001 
(Van den Berg et al. 2006). Thus, at a concentration of 3.4 μM, PCB-77 would be 
anticipated to be approximately equipotent to 0.1 nM TCDD. At low concentrations 
of PCB-77 (3.4 μM), oil red O staining increased (Figure 3). Modest elevations in oil 
red O staining with low concentrations of TCDD (0.1 nM) were not significant 
compared with vehicle (Figure 3B). Higher concentrations of each toxic compound 
resulted in a reduction in oil red O staining (Figure 3A). Because adipocytes were 
not clearly visible with high concentrations of TCDD or PCB-77, we did not quantify 
oil red O staining at high concentrations. The AhR antagonist α-NF decreased oil 
red O staining (Figure 3B). In addition, α-NF decreased PCB-77 (3.4 μM)-induced 
elevations in oil red O staining. In contrast to findings with lower concentrations of 
PCB-77 (3.4 μM), a higher concentration of PCB-77 (68 μM) and TCDD resulted in 
a reduction in release of proinflammatory adipokines from adipocytes when 
incubated with preadipocytes during differentiation (Table 2). 
 In vivo administration of PCB-77 increases body weight gain in C57BL/6, but not in 
AhR−/− mice  
To determine if the in vitro effects of PCB-77 occur with in vivo exposure and 
whether these effects are AhR-mediated, we administered PCB-77 to C57BL/6 wild-
type (WT) and AhR−/− mice. AhR-deficient mice administered vehicle exhibited 
lower body weight gain than vehicle-injected WT controls (Figure 4). In WT, mice 
administered PCB-77, body weight gain increased at 1 and 5 weeks compared with 
vehicle. In contrast, body weight gain did not increase in AhR−/− mice administered 
PCB-77.  
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In vivo administration of PCB-77 results in increased body weight and adipose 
mass, elevated serum cholesterol concentrations, and increased atherosclerosis in 
ApoE−/− mice  
To determine whether elevations in body weight would promote obesity-
associated atherosclerosis, we defined effects of PCB-77 in hyper-cholesterolemic 
ApoE−/− mice. Body weight (28.0 ± 0.70 g for vehicle; 30.4 ± 0.30 g for PCB-77; p < 
0.05; Figure 5A) and weight gain (1.28 ± 0.4 g for vehicle; 2.62 ± 0.30 g for PCB-77; 
p < 0.05) were higher in PCB-77− treated mice compared with vehicle-treated mice. 
Increases in body weight were associated with increases in the mass of gonadal 
[epididymal fat (EF)] and visceral [retroperitoneal fat (RPF)] adipose tissue as well 
as the liver (Figure 5B). In tissue sections from mesenteric white adipose tissue, 
adipocytes from mice injected with PCB-77 were hypertrophied compared with 
those from vehicle-treated mice (Figure 5C, D). The concentration of PCB-77 in EF 
was higher in mice administered PCB-77 (55 ± 8 μg/g) than in vehicle-treated 
animals (< 0.6 μg/g). Moreover, PCB-77 was not detected in the plasma of vehicle-
injected mice, but it was within detectable concentrations in mice administered 
PCB-77 (0.365 μg/g). Total serum cholesterol concentrations were markedly 
increased in ApoE−/− mice injected with PCB-77 compared with vehicle (Figure 
6A). Elevations in serum cholesterol concentrations in PCB-77− treated mice were 
predominantly in very low-density lipoprotein (VLDL) cholesterol (Figure 6B). 
Moreover, compared with vehicle-treated mice, tissue sections of liver from mice 
administered PCB-77 exhibited lipid-laden vacuoles (Figure 6C). Unexpectedly, 
administration of PCB-77 resulted in marked deposition of lipid within the abdominal 
cavity (Figure 6D). The extent of atherosclerosis was low in aortic root sections of 
ApoE−/− mice administered vehicle (Figure 6E). Administration of PCB-77 to 
ApoE−/− mice increased atherosclerosis in aortic root sections (0.002 μm2 mean 
lesion area in PCB-77− injected mice; nondetectable in vehicle controls; p = 0.032; 
Figure 6E).  
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 Table 2.1. Primer sequences for real-time PCR. 
Gene Forward Reverse 
18S CTCTGTTCCGCCTAGTCCTG AATGAGCCATTCGCAGTTTC 
PPARγ GATGGAAGACCACTCGCATT AACCATTGGGTCAGCTGCTCTTG 
aP2 TCACCTGGAAGACAGCTCCT AAGCCCACTCCCACTTCTTT 
CD36 AGGTCCTTACACATACAGAGTTCG GGACTTGCATGTAGGAAATGTGGA
Adiponectin GTTGCAAGCTCTCCTGTTCC ATCCAACCTGCACAAGTTCT 
Angioten- 
sinogen 
TCTCTTACCCCTGCCCTCT GAACCTCTCATCGTTCCTTG 
 
 
 
Table 2.2. Adipokines released from 3T3-L1 adipocytes treated with vehicle/PCB77 
μM MCP-1 (pg/mL) 
Adiponectin 
(pg/mL) 
Leptin 
(pg/mL) 
IL-6 
(pg/mL) 
KC-1 (pg/mL)
Vehicle 3,069 ± 297 43,200 ± 1,400 7.78 ± 2.3 5.6 ± 0.1 2,912 ± 321 
PCB-77 (3.4) 7,217 ± 1,238* 16,550 ± 250* 4.98 ± 1.7 8.6 ± 2.3 4,820 ± 794* 
PCB-77 (68) 1,510 ± 128 129 ± 80* < 3.00 2.8 ± 0.1 < 3.00 
TCDD (10nM) 2,810 ± 430 1,106 ± 325* < 3.00 3.8 ± 0.7 < 3.00 
IL-6, interleukin 6. Data are mean ± SE from three per treatment. 
*Significantly different from vehicle (p < 0.05). 
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Figure 2.1. Effect of PCB-77 and PCB-153 on adipocyte differentiation and mRNA 
expression of proinflammatory adipokines. (A) Macroscopic (left) and microscopic 
(right; 40× magnification) images of oil red O–stained adipocytes. (B) Quantification 
of oil red O staining. (C) mRNA expression of PPARγ, aP2, Ao, TNF-α, CD36, and 
adiponectin. Data are mean ± SE from five individual experiments.*Significantly 
different from vehicle (p < 0.05). 
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Figure 2.2 . Effect of PCB-77 and PCB-153 on mRNA expression of 
proinflammatory adipokines in mature 3T3-L1 adipocytes. (A) GPDH activity (left) or 
oil red O staining (right). (B) mRNA expression of PPARγ, aP2, Ao, or CD36. Data 
are mean ± SE from five individual experiments.*significantly different from vehicle 
(p < 0.05). 
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Figure 2.3 . Effects of low and high concentrations of PCB-77 and TCDD on 
adipocyte differentiation (effects of PCB-77 are AhR mediated). (A) Oil red O 
staining (representative images from three individual experiments; 20× 
magnification). (B) Quantification of oil red O staining. Data are mean ± SE from 
three experiments. *Significantly different from vehicle (p < 0.05). **Significantly 
different from PCB-77/α-NF (p < 0.05). 
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Figure 2.4. Effect of PCB-77 on body weight gain in WT C57BL/6 and AhR−/− mice. 
Arrows indicate times of vehicle or PCB-77 injections. Data are mean ± SE from 10 
mice per group. *Significantly different from vehicle, within genotype.     
 
 
                    
(weeks) 
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Figure 2.3 . Effects of low and high concentrations of PCB-77 and TCDD on 
adipocyte differentiation (effects of PCB-77 are AhR mediated). (A) Oil red O 
staining (representative images from three individual experiments; 20× 
magnification). (B) Quantification of oil red O staining. Data are mean ± SE from 
three experiments. *Significantly different from vehicle (p < 0.05). **Significantly 
different from PCB-77/α-NF (p < 0.05). 
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Figure 2.6. Effects of PCB-77 on total serum cholesterol and VLDL cholesterol. 
Lipid deposition within the liver and abdominal cavity, and atherosclerosis in 
ApoE−/− mice. (A) Total serum cholesterol concentrations (n = 10 mice per group). 
(B) Lipoprotein cholesterol distributions (n = 4 mice per group). (C) Representative 
tissue sections from livers of mice injected with vehicle or PCB-77. (D) Abdominal 
cavity from mice administered vehicle or PCB-77. (E) Aortic root sections stained 
with oil red O from vehicle or PCB-77− injected mice. *Significantly different from 
vehicle (p < 0.05). 
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Discussion 
It has long been recognized that the high lipophilicity of PCBs and related 
toxic compounds favors their localization to adipose tissue. However, their effects 
on adipocyte function have not been established. Our results suggest that lower 
concentrations of coplanar PCBs, acting as ligands of the AhR, promote adipocyte 
differentiation and increase the expression of proinflammatory adipokines. In 
contrast, higher concentrations, similar to TCDD, inhibit adipocyte differentiation. 
Importantly, when administered to WT, but not AhR-deficient mice, PCB-77 caused 
an increase in body weight gain. These results confirm in vitro findings and suggest 
that effects of PCB-77 are AhR mediated. In hypercholesterolemic  ApoE−/− mice, 
PCB-77 increased body weight associated with adipocyte hypertrophy, expanded 
adipose mass, and increased serum cholesterol concentrations and ectopic lipid 
deposition. These effects of PCB-77 were associated with increased 
atherosclerosis. These results suggest that exposure to PCB-77, a dioxin-like PCB, 
at relatively low levels may promote the development of obesity and obesity-
associated atherosclerosis.  
PCBs are highly lipophilic, with octanol: water partition coefficients of ≥ 104, 
making their accumulation in nonlipid material negligible. In studies aimed at 
determining the congener-specific distribution of PCBs with chronic exposure, adult 
rats were treated five times per week for 4 weeks by gavage with Aroclor 1254 in 
corn oil [13].[24] Total PCB (parts per milllion) accumulation in fat was 551 μg/g; the 
second-highest tissue accumulation of PCBs was in liver (38 μg/g). The mean 
blood:liver:fat tissue ratios were 1:22:359, similar to previously observed results for 
PCB-153 (Wyss et al. 1986) or 2,2′3′,4,4′,5,5′-heptachlorobiphenyl (PCB-180) [24] 
In the present study, adipocyte differentiation and proinflammatory adipokine 
expression were induced in 3T3-L1 adipocytes by PCB-77 but not by PCB-153. 
These PCB congeners differ slightly in their oil: water partition coefficients, favoring 
greater lipophilicity of PCB-153; however, both PCBs would be anticipated to 
accumulate in adipose tissue. A lack of effect of PCB-153 may have resulted from 
greater sequestration of this more-lipophilic PCB in the triacylglycerol droplet of the 
adipocyte, leaving less PCB-153 available to act at adipocyte target proteins. 
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However, given that PCB-77 and TCDD exhibited similar effects and that TCDD has 
a high octanol: water partition coefficient comparable to PCB-153 (6.7 vs. 6.8, 
respectively), other mechanisms most likely mediated differences in effects of PCB-
77 and PCB-153.  
Specifically, results from this study demonstrate that interactions with the 
AhR, for which both PCB-77 and TCDD possess affinity (but PCB-153 has low 
affinity), contributed to differences in the effects of these PCBs. Phillips et al. (1995) 
demonstrated that treatment of 3T3-L1 preadipocytes with 10 nM TCDD during the 
first 2 days of induction of differentiation resulted in a reduction in the number of fat 
cell colonies. The effect of TCDD to inhibit adipocyte differentiation was blocked by 
treatment with an AhR antagonist. To extend these findings to the in vivo situation, 
Brodie et al.[25]demonstrated that a single high dose (175 μg/kg) of TCDD 
administered to rats resulted in inhibition of adipocyte differentiation. Additional 
studies by this group demonstrated that high-dose TCDD treatment in rats resulted 
in a reduction in preadipocytes differentiation to mature adipocytes, which was 
associated with decreases in transcription factor mRNAs (PPARγ, aP2, C/EBPβ) 
normally elevated during adipocyte differentiation[25].  Using the 3T3-L1 adipocyte 
differentiation system, Shimba et al. [23] demonstrated that the level of AhR protein 
decreased with ongoing adipocyte differentiation. Using mouse embryo fibroblasts, 
Alexander et al. [26] demonstrated that treatment with 10 nM TCDD inhibited 
differentiation in cells from WT but not AhR−/− mice. At high concentrations 
(approximately 10-fold greater than the dissociation constant), the literature and 
data from this study demonstrate that TCDD decreases adipocyte differentiation, 
commensurate with the wasting syndrome demonstrated from high-dose toxicity.  
Several epidemiologic studies have suggested a link between exposure to 
dioxin, or PCBs, and diabetes[27] [18, 28-31] Most of these studies represent 
findings from type 2 diabetics with obesity; however, increased relative risk for 
exposure to toxic compounds and the development of diabetes remains when data 
were adjusted for differences in body mass index across study populations. 
Interestingly, the association between persistent organic pollutants and diabetes 
was much stronger in obese subjects compared with lean subjects [32]. Moreover, 
in nondiabetic adults, results from the National Health and Nutrition Examination 
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Survey (1999–2002) [32] demonstrated a linear positive relationship between serum 
concentrations of PCBs, including dioxin-like PCBs, and waist circumference. 
Unfortunately, similar epidemiologic studies have not been performed to define 
whether exposure to PCBs increases the risk for development of obesity or obesity-
associated cardiovascular disease, including atherosclerosis.  
Obesity, a condition that would predictably increase the body burden of 
lipophilic PCBs, is associated with an elevation in the systemic concentrations of a 
variety of factors that are produced and released from adipocytes [33, 34]. Many of 
these factors have been linked to diseases clustering around an obesity phenotype, 
including coronary artery disease, the primary cause of death in the obese 
population. Thus, factors that regulate adipokine secretion from adipocytes may 
influence not only obesity but also obesity-associated atherosclerosis. The present 
results demonstrate that PCB-77 promotes the expression and secretion of a variety 
of proinflammatory adipokines from 3T3-L1 adipocytes and decreases the 
expression of adiponectin, an anti-inflammatory adipokine. Although previous 
studies have demonstrated proinflammatory effects of PCBs in various cell 
types[35] [19, 20, 36][37], to our knowledge, this is the first report demonstrating 
that PCBs can promote the production and elaboration of these factors from 
adipocytes. Interestingly, Vogel et al. [38] [39]recently reported that a single 
injection of TCDD into C57BL/6 mice resulted in an increase in MCP-1 and KC-1 in 
liver and adipose tissue. However, enhanced expression of these adipokines in 
adipose tissue was associated with increased expression of the macrophage 
marker F4/80, suggesting that this effect may have resulted from enhanced 
macrophage infiltration into adipose tissue.  
Our results extend these findings by demonstrating that PCB-77 can act 
directly on 3T3-L1 adipocytes to promote the mRNA abundance and secretion of 
several pro-inflammatory adipokines. To extend results from in vitro experiments to 
an in vivo model, we administered PCB-77 to WT or AhR-deficient mice or to hyper-
cholesterolemic ApoE−/− mice. In previous studies, C57BL/6 mice that received 30 
mg/kg/day of PCB-77 consumed in food for a total of 16 weeks exhibited a 
reduction in body weight [39]. Thus, chronic dosing with high doses of PCB-77 
appears to mimic the wasting syndrome that results from toxic TCDD exposure.  
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In the present study, we injected mice four times (49 mg/kg per dose) with 
PCB-77 over a 6-week period; although this was a higher daily dose than used by 
Goodwill et al.[39], it was far less cumulative. Our choice of PCB-77 dose was 
based on previous studies demonstrating that this dose exhibits proinflammatory 
effects on endothelial cells when injected into mice [20] and is classified as a 
moderate exposure dose in experimental animals[40, 41] [42]. In agreement, PCB-
77 levels in adipose tissue of mice from this study were far lower than those 
reported in adipose tissue from rats administered Aroclor [55 vs. 551 μg/g;[13]].  
Our results demonstrate that in contrast to high-dose PCB-77 dosing in vivo, 
lower doses exhibit an opposite effect to increase body weight. Moreover, these 
effects were AhR mediated. The ability of PCB-77 to increase adipose mass with 
associated adipocyte hypertrophy may relate to the in vitro effects of PCB-77 to 
promote adipocyte differentiation. Alternatively, the ability of PCB-77 to increase 
CD36 mRNA abundance in adipocytes may have promoted lipid uptake and 
contributed to adipocyte hypertrophy. Previous investigators demonstrated that 
dietary exposure to PCBs results in fatty liver and hypercholesterolemia in rats[43-
45]. These effects were primarily attributed to an increase in hepatic cholesterol 
synthesis. In the present study, a low dose of PCB-77 resulted in a marked increase 
in serum cholesterol concentrations in ApoE−/− mice, with predominant increases in 
VLDL cholesterol.  
These results extend previous findings by demonstrating that in a mouse 
model exhibiting hyper-cholesterolemia and atherosclerosis, marked elevations in 
serum cholesterol concentrations are induced by PCB-77. Moreover, elevations in 
VLDL cholesterol by PCB-77 in this study were associated with increased 
atherosclerosis. To our knowledge, this is the first study that has directly examined 
the effects of PCB exposure on experimental atherosclerosis. In conclusion, at low 
exposure levels, coplanar PCB-77 promoted adipocyte differentiation and 
proinflammatory adipokine expression. In contrast, both PCB-77 and TCDD 
inhibited adipocyte differentiation at higher concentrations. Effects of PCB-77 to 
promote adipocyte differentiation and regulate body weight were AhR mediated. 
Importantly, when administered in vivo to ApoE−/− mice at a moderate dose, PCB-
77 resulted in an increase in body weight, adipose mass and adipocyte area, serum 
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cholesterol concentrations, and atherosclerosis. These results suggest that low-
level exposure to coplanar PCBs may contribute to the development of obesity and 
to obesity-associated atherosclerosis. 
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Chapter Three  
INCREASED ABDOMINAL AORTIC ANEURYSM SEVERITY IN 
APOLIPOPROTEIN DEFICIENT MICE AFTER EXPOSURE TO DIOXIN-LIKE 
TOXICANTS 
 
Synopsis 
Objectives: Infusion of AngII to hyperlipidemic mice (ApoE-/-) causes the 
formation of abdominal aortic aneurysm (AAA). Male sex and smoking are the main 
risk factors for AAA. Considerable amounts of dioxin-like components have been 
found in cigarette smoke. Dioxin-like toxicants, like polychlorinated biphenyls (PCB 
77), are highly lipophilic and trigger pro-inflammatory gene expression in the 
cardiovascular system and adipose tissue. In this study, we investigated whether 
exposure to PCB77 would augment the development of AngII-induced AAA 
formation and perianeurysmal inflammation. 
 Methods and Results. Male, apoE-/- mice, received 4 doses of vehicle or 
PCB 77 (i.p.- 150mmol/Kg) during a 4 week subcutaneous infusion of AngII 
(1,000ng/kg/min).  We monitored body weight, blood pressure and the aneurysm 
formation and progression using high-frequency ultrasonography. PCB 77 
increased body weight by expanding  visceral adipose tissue and liver mass of 
AngII-infused mice. Blood pressure and total serum cholesterol was increased in all 
groups. Total cholesterol and free fatty acid (NEFA) were increased in the group 
receiving PCB 77. AAA incidence and severity were increased in mice injected with 
PCB 77 (9 out of 10) compared to vehicle (2 out of 5) or AngII group (5 out of 11). 
We found that PCB77 was preferentially accumulated in the visceral adipose tissue. 
Furthermore, PCB 77 treatment induced proinflammatory adipokines, angiotensin, 
AT1 and macrophage accumulation in the perianeurysmal adipose tissue while 
decreasing adiponectin.  
 Conclusions. Persistent exposure to dioxin like residues can increase AAA 
severity and mortality.  Smoking cessation and avoidance of fatty foods containing 
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dioxin-like toxicants represent viable approaches for medically managing patients 
with AAA.   
Introduction 
In the United States abdominal aortic aneurysm (AAA )occurs in up to 9% of 
adults over the age of 60 years, and accounts for over 16,000 deaths annually[46]. 
AAA is a silent disorder among cardiovascular diseases, too often without 
symptoms until the catastrophic event of aneurysm rupture. Several large studies 
have addressed the epidemiology of AAA [47-49] and found that risk factors include 
age of 60 or above, smoking, having a family history of aortic aneurysm, and having 
other conditions that affect the blood vessels, such as heart disease or diabetes. 
Importantly, men are more likely to have an aortic aneurysm than women (4:1). 
Although atherosclerosis and hypertension are often associated with abdominal 
aortic aneurysm, disturbances in the connective tissue metabolism may also be 
involved [50-53]. 
 The prevalence of AAA increases strongly with male gender, age and 
smoking especially and positively correlates with waist-hip ratio. An aging, 
overweight population is likely to lead to a continued increase in the number of 
patients with clinical aortic aneurysm[54] as an important cardiovascular pathology 
in older people. 
An often ignored, but very potent risk factor for medical problems in 
industrialized countries is the environmental pollution. For example, aortic 
aneurysms are more likely in smokers over 60 with a family history of the condition. 
Dioxins and dioxin like components are among the most persistent contaminants 
found in food, air and cigarettes [11, 55].  In addition, due to their lipophilic 
properties, they will bioaccumulate and biomagnify in the trophic chain with known 
dispersion in the adipose tissue [56-59]. Organisms higher in the food chain and 
with a higher ratio of adipose tissue demonstrate higher levels of contamination. 
Importantly, with the obesity pandemic, the quantity of these pollutants trapped in 
the adipocytes will increase [60, 61]. Although their involvement in diseases of the 
vasculature by compromising normal functions of vascular endothelial cells has 
been already studied [62] their silent action and chronic accruement in the 
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perivascular fat has not been evaluated in the context of the processes that drive 
abdominal aortic aneurysm morbidity and mortality. 
In this study, we used an apoE-/- mouse model of Angiotensin II induced AAA 
[63].  One aspect of this model, that shows similarities with the human disease is its 
gender preference, with a higher incidence and more severe aneurysms in males 
versus females [64]. Another important and common feature of this model with the 
human AAA is that, although severe hyperlipidemia is not required for AAAs 
formation, its presence augments the incidence  and severity of aneurysms [64, 65] 
and cardiovascular co-morbidities [66-68] 
 For men and women, smoking is strongly related to AAA occurrence [49, 69-
72]. The aryl hydrocarbon receptor (AhR) is the receptor for the dioxin like 
compounds found in tobacco smoke and for coplanar PCBs (PCB 77), ubiquitously 
distributed in the environment [73, 74]. Comparable with smoking, chronic exposure 
to low doses of PCB 77, an AhR agonist, may contribute to increased incidence and 
severity of AAA. Conversely, cessation of smoking and reducing the consumption of 
food with high concentration of PCB would have a positive impact in AAA morbidity 
and mortality. 
In conclusion, we showed that chronic exposure to PCB 77 is an additive risk 
factor for AngII-induced inflammatory AAA in male apoE-/- mice. PCB 77 
accumulated in the visceral fat and induced ectopic fat deposition in the liver. PCB 
77 increased circulating nonesterified free fatty acids (NEFA) contributing to the 
disturbances in the lipid metabolism. Hallmarks of modern-day diseases, pollution, 
overeating and sedentarism would only contribute to the already high prevalence of 
cardiovascular diseases 
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Materials and Methods 
Angiotensin II was purchased from Sigma-Aldrich Corp, St. Louis, MO) and 
3,3',4,4' tetrachlorobiphenyl (PCB 77)  was obtained from AccuStandard Inc. (New 
Haven, CT)  and were > 99% pure. 
Animals  
Male apoE-/- mice (3 months of age, bred in house to C57BL/6 mice from 
stock originally purchased from The Jackson Laboratory, Bar Harbor, ME) were 
housed in a pathogen free environment with water and normal laboratory diet ad 
libitum.  Mice were randomly assigned to three separate groups (AngII+Vehicle, 
AngII, AngII+PCB 77). At study endpoint, mice were anesthetized with 
ketamine/xylazine (100/10 mg/Kg, i.m.) for plasma and tissue harvest (adipose 
depots, aorta, liver). Pictures of the ex-vivo AAA were taken and aneurysms graded 
by 3 independent observers as previously described [64]. All procedures involving 
animals were approved by the Institutional Animal Care and Use Committee at the 
University of Kentucky.  
AngII Infusion  
Alzet  osmotic minipumps (model 2004), (Durect Corp; Cupertino, CA) were 
filled with AngII (for infusion rate of 1000ng/Kg/min) as described previously [63, 
75]. Pumps were implanted subcutaneously, in the interscapular region. Mice were 
anesthetized with ketamine/xylazine (100/10 mg/Kg, i.m.). All incision sites were 
closed with surgical glue and allowed 24 h for adjustment before AngII infusion 
started. There was no infection present during healing and no antibiotics were used. 
PCB 77 Treatment and measurement in plasma and tissue  
Four intra-peritoneal injections were administrated during the first and last 
week of AngII infusion: mice received either vehicle (safflower oil, 0.4 ml) or PCB 77 
(150mmol/Kg, 0.4 ml). For PCB 77 plasma and tissue concentration we used a 
Dionex ASE 200 system (Dionex Corporation, Sunnyvale, CA) for assisted solvent 
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extraction and gel permeation chromatography/mass spectrometry, as described 
previously [58, 76]. 
Blood pressure measurements  
Systolic blood pressure was measured on conscious restrained mice, after 
acclimatization, using a tail cuff system as described previously [63, 75, 77]. For 
each trained mouse, ten measurements were taken and analyzed with a data 
acquisition system (Visitech, Kent Scientific, Litchfield, CT). 
 
Measurement of serum and plasma components 
Serum cholesterol, triglyceride and free fatty acids concentration were 
determined in fasting plasma samples using enzymatic assay kits (Wako Pure 
Chemical, Richmond, VA). Lipoprotein cholesterol distribution were evaluated in 
individual serum samples (50µl) after fractionation by size exclusion fast protein 
liquid chromatography (FPLC) gel filtration (Pharmacia LKB Biotechnology, 
Uppsala, Sweden) on a single Superose 6 column [78]. Plasma renin concentration 
was measured by generation of angiotensin I in the presence of excess 
angiotensinogen (Sigma-Aldrich Corp., St. Louis, MO) substrate as described 
previously [79]. 
Quantification of AAAS 
Aneurysm incidence was quantified by grading of ex-vivo, clean tissue by 
three independent observers blinded to the experimental design as described 
previously. In-vivo, aneurysm incidence was quantified by ultrasound as an aortic 
diameter greater than 1.5 times the normal diameter measured above the level of 
the renal arteries.  
We used a high resolution ultrasound imaging system - Visualsonics Vevo 
660- that performs two dimensional imaging (B mode) by using a real time micro 
visualization scan-head (RMV 704) with a frequency of 40 MHz and a focal length of 
6 mm (Visualsonics, Toronto, Canada). Mice were anesthetized with 
ketamine/xylazine and abdominal region was prepared. At 0, 14, and 28 days after 
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initiation of AngII infusion aortic images were acquired on a short axis scan at the 
level of left renal artery and throughout the renal region using ultrasound 
transmission gel. Two diameters were used to average the aneurysm size in cine 
loops 300 frames for each mouse [80, 81]. 
Histology 
Abdominal aortas and perianeurysmal fat were placed in 4% fresh 
paraformaldehyde at room temperature. After fixation, tissues were embedded in 
paraffin and 5 µm serial sections were obtained. After deparaffinization, sections 
were stained with hematoxylin and eosin. 
Analysis of mRNA levels in perianeurysmal adipose tissue by Real Time 
PCR 
Total RNA was purified using MagnaPure Compact RNA Isolation Kit 
(Roche, Indianapolis, IN) according to the manufacturer’s directions. RNA was 
reverse transcribed to generate cDNA templates using the Transcription High 
Fidelity cDNA Synthesis Kit (Roche). Specific mRNA levels were quantified by real-
time RT-PCR, using the iCycler (Bio-Rad, Hercules, CA), IQ SYBR Green Supermix 
(Bio-Rad), and the specific primers indicated in Table I. Primers were designed 
using the Primer 3 software (SourceForge, Mountain View, CA).  The mRNA level of 
2 reference genes which did not vary between groups were used to normalize 
mRNA levels for test genes according to the 2 ─ ∆∆CT method.  The formula used was  
[2─ (CT test – CT reference)] x 100%.  
Immunohistochemistry  
The 5 μm thick, serial aorta and perianeurysmal fat sections were 
deparaffinized, rehydrated, and treated for 10 min with a citric acid-based antigen-
unmasking solution (Vector Laboratories, Burlingame, CA). Sections were blocked 
with normal goat serum (1% in PBS) and incubated overnight at 4°C with primary 
antibodies diluted (1:50) in blocking buffer.  Primary antibody used: Angiotensin II 
(BGN/0856/21) - a mouse anti-human monoclonal antibody, Angiotensin Receptor 1 
( AT1 - 306:sc-579) - a rabbit  anti-human polyclonal antibody, CD68 (CD68 - H-
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170:sc-20791) - a rabbit anti-human polyclonal  antibody, (all from Santa Cruz 
Biotechnology, INC.). After washing, sections were incubated for 1 h with a mixture 
of Cy2-conjugated goat anti-mouse IgG or Cy3-conjugated goat anti-rabbit IgG 
(Jackson ImmunoResearch Laboratories, West Grove, PA, catalog numbers 115-
225-146 and 111-165-144). Sections were counterstained with 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Molecular Probes Invitrogen, Eugene, OR) to 
visualize nuclei, and mounted with VECTASHIELD® medium (Vector Laboratories). 
Images were obtained with an Olympus BX51 microscope, using a 20x objective. 
Image-ProPlus 5.0 software (Media Cybernetics, Inc.) was used to generate the 
composite images.  
 
  Statistical analysis 
Data are expressed as mean ± SEM. Data were analyzed using GraphPad 
Prism 5 (GraphPad Software Inc., San Diego, CA) by parametric or nonparametric 
analysis as appropriate. One- or two-way ANOVA were used depending on the 
number of experimental variable. For post hoc analysis, data were analyzed using 
Tukey’s test. For aneurysms incidence Fisher exact test was used. For all analyses, 
P<0.05 was considered to be statistical significant. 
 
 
Results 
PCB 77 accumulates in visceral fat and increases the expression of its 
receptor, AhR.   Male, apoE-/- mice were fed a normal laboratory diet for 6 weeks. 
On week two they were injected two times with vehicle (safflower oil - 0.4ml ) or 
PCB 77 (0.4ml), then implanted with miniosmotic pumps for a four week infusion of  
Ang II. On week six of the study they were injected two more times with vehicle or 
PCB 77. ApoE-/- mice that received PCB 77 had an increased accumulation of this 
toxicant in visceral fat (79 ± 11 µg/g) compared with plasma (< 0.6 µg/g), (Fig.3.1 
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A), and immunohistochemistry showed increased AhR staining in perianeurysmal 
adipose tissue (Fig.3.1 B).  
PCB 77 augmented AngII-induced AAA in apoE-/- mice. 
 To determine the role of PCB 77 in AAA formation and progression, the 
incidence and severity of AngII-induced AAAs was compared between mice that 
received AngII (1000ng/Kg/min) and mice that received AngII and PCB 77 
(150mmol/Kg body weight). AngII infusion induced a 45% ( 5/11 ) incidence of 
AAAs in apoE-/- mice following 28 days of AngII infusion whereas PCB77 
augmented AngII-induced AAA to 90% ( 10/11) (Fig.3.2 A). AAA severity was 
categorized ex-vivo from Type I to Rupture using a previously established 
classification [82]. There were 2 ruptures in the AngII-PCB77 group compared to 
none in the  AngII group (Fig.3.2 B). In Ang + Vehicle (n=6) treated mice there was 
50% incidence of AAA and no rupture, same as in the Ang group. 
The diameters of the supra-renal abdominal aorta were measured using 
ultrasound on day 0, 14 and 28 of the AngII infusion. Normal abdominal aortic 
diameter does not exceed 1 mm, whereas the same aortic region from AngII and 
AngII-PCB77 treated mice ranged from 1.5 to 2.25 mm respectively (Fig.3.3 A, B). 
PCB 77 significantly increased the AngII-induced AAA diameter in apoE-/-mice. H& 
E staining show an increased diameter, aortic wall thickness and thrombotic 
material in AAA induced by AngII+PCB 77 treatment (Figure 3.3 C).   
PCB 77 increased visceral and liver weight of apoE-/- mice. Mice receiving 
PCB77 gained weight and at the end of the study they were heavier than their 
littermates treated with AngII Fig.3.4 A). Increases in body weight were associated 
with visceral fat hypertrophy (Fig. 3.4 B, C) and ectopic fat deposition in liver (Fig. 
3.4 B, D) in apoE-/- mice after six weeks of normal chow diet. PCB 77 was 
undetectable in the plasma or visceral fat of Ang+Vehicle or AngII infused mice 
(data not shown). 
PCB 77 significantly increased total cholesterol and NEFA (Fig.3.5) 
emphasizing a positive correlation between the aneurysm severity and cholesterol 
level similar with the human disease. 
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PCB 77 induced proinflammatory cytokines and macrophage accumulation in 
the perianeurysmal adipose tissue. ApoE-/- mice receiving Ang+PCB 77 showed an 
increase in proinflammatory cytokines like TNFα, IL1β and the chemokine MCP1 in 
adipose tissue surrounding the aneurysm (Fig.3.6 A). Immunohistochemistry 
showed increased CD68 staining, as a marker for macrophage accumulation in the 
perianeurysmal fat (Fig 3.6 B) and the AAA adventitia (Fig 3.7). 
PCB 77 activates components of the Renin-Angiotensin System (RAS).  
ApoE-/- mice receiving Ang+PCB 77 had an increase plasma level of renin (Fig.3.8 
A) and mRNA gene expression of Angiotensinogen, AT1a and ACE in the 
perianeurysmal fat (Fig.3.8 B) Immunohistochemistry detected increased Ang II and 
AT1a proteins in the adventitia (Fig.3.9) and  adipose tissue surrounding the AAA 
(Fig 3.8 C).     
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Figure 3.1. PCB-77 accumulates in visceral fat of mice treated with PCB 77.       (A) 
Quantification of PCB 77 in visceral fat and plasma (B) Immunohistochemistry for 
AhR - red (20× magnification). ** (p < 0.005). 
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Figure 3.2. PCB-77 augmented Ang-induced AAA incidence and severity  (A) AAA 
percentage incidence (B) AAA classification. (C) AAA representative pictures. Data 
are mean ± SEM  from 10/11 mice per group. *significantly different from Ang only 
(p < 0.05). 
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Figure 3.3 . PCB 77 significantly increased the AngII-induced AAA diameter in 
apoE-/-mice. (A) Aorta diameters (mm). (B) Ultrasound images at 0 (left), 14 
(middle), 28 (right) days. (C) H&E for AAA 5 microns sections. Data are mean ± 
SEM from all mice. *Significantly different from baseline (p < 0.05) 
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Figure 3.4. PCB 77 increased body weight gain of apoE-/- mice.(A) Body weight 
gain, arrows indicate times of PCB-77 injections. (B) Visceral fat (left) and  liver 
(right) percentage from total body weight. (C) H&E tissue sections - 5μm from 
visceral fat or liver (40-60x magnification).  Data are mean ± SEM from all mice. 
*Significantly different (P<0.05); ** P<0.001 
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Figure 3.5. Effects of PCB-77 on NEFA and total serum cholesterol in ApoE−/− 
mice. (A) NEFA concentration in plasma (B) Total serum cholesterol  Data are 
mean ± SEM from 6 mice per group. *Significantly different from Ang group (p < 
0.05). 
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Figure 3.6. PCB 77 induced proinflammatory cytokines and macrophage 
accumulation in the perianeurysmal adipose tissue. (A) mRNA gene expression in 
perianeurysmal fat (B) Fluorescence Immunohistochemistry for CD68 (green); 5μm 
sections from perianeurysmal adipose tissue. Data are mean ± SEM from 6 mice 
per group *Significantly different from Ang (p < 0.05); ** P<0.002 
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Figure 3.7. PCB 77 induced macrophage accumulation in the AAA adventitia. 
Representative pictures from Fluorescence Immunohistochemistry for CD68 
(green); 5μm sections from AAA adventitia ( 40x magnification). Blow-up detail at 
60x magnification. 
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Figure 3.8. PCB 77 activates components of the Renin-Angiotensin  System (RAS). 
(A) Plasma renin concentration (B) mRNA gene expression for Ao, AT1, ACE and 
AdipoQ.(C) Fluorescence Immunohistochemistry for Ang (green) and AT1 (red); 
5μm sections from perianeurysmal adipose tissue. Data are mean ± SEM from 6 
mice per group *Significantly different from Ang (p < 0.05); ** P<0.002 
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Figure 3.9. PCB 77 induced Ang peptide accumulation in the AAA adventitia. 
Representative pictures from Fluorescence Immunohistochemistry for Ang (red); 
5μm sections from AAA adventitia (40x magnification). Details are at 60x 
magnification. 
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Figure 3.10. Male patients w ith abdominal aortic  aneur ysm. 85% of males 
patients with abdominal aortic aneurysms that have been admitted to cardiovascular 
surgery have  indicated  that are smokers and 30% them have BMI over 30. Data 
are mean ± SEM. * significant from control (p<0.05); ** p< 0.001 
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Discussion 
 
Environmental exposure to dioxin-like toxicants has been associated with 
several medical conditions. The current study addressed the effect of a 
representative compound, PCB 77, on the development of abdominal aortic 
aneurysm in an established murine model. We have recently found that PCB 77 
promotes adipocyte maturation and production of inflammatory cytokines and 
adipokines. Inflammation within the perivascular fat depot promotes vessel wall 
damage [83, 84]. Moreover , microarray studies in apoE-/- mice treated with 
angiotensin demonstrated a characteristic upregulation in pro-inflammatory 
cytokines within the aorta of mice that developed aneurysm[85].  
Cigarette smoke contains a mixture of dioxin-like compounds, including PCB 
77[11], and is one of the most important factors implicated in the etiology of aortic 
abdominal aneurysms[71, 86]. Our preliminary observations among males with 
abdominal aneurysms indicate that 85% are smokers and 30% have BMI over 30 
(Suppl. Fig 10). Therefore, our experiments with PCB 77 in male mice with 
abdominal aneurysm are highly relevant for the human disease. Men and women 
are chronically exposed to these pollutants through smoking, contaminated air and 
food products [56]. These compounds are highly lipophilic, and thus passively 
accumulate in the adipose tissue. Nevertheless, the consequences on 
cardiovascular diseases have not been established. Our results suggest that apoE-
/- mice exposed concomitantly to AngII and lower doses of dioxin-like PCB 77 (four 
doses of 49 mg/kg )[87, 88] exhibited increased aneurysm incidence and severity. 
Furthermore, apoE-/- mice receiving PCB 77 alone had more significant 
atherosclerotic deposits within the aortic arch and root, compared to control [58]. 
Importantly, apoE-/- mice exposed to PCB 77 gained weight and exhibited visceral 
adipocyte hypertrophy, adipose mass accretion, higher NEFA concentration and 
ectopic lipid deposition. These results indicate that low levels of dioxin-like PCB77 
may promote atherosclerosis, obesity and metabolic syndrome, while augmenting 
the effects of AngII on formation and severity of abdominal aneurysm in apoE-/- 
mice. 
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          In studies aimed to determine the function of vascular endothelial cells 
exposed to PCB 77, Hennig et al [62], had previously shown that 3,3',4,4'-
tetrachlorobiphenyl (PCB 77), an aryl hydrocarbon receptor (AhR) agonist, can 
cause disruption of endothelial barrier function. This was supported by an increase 
in oxidative stress as measured by enhanced 2',7'-dichlorofluorescein (DCF) 
fluorescence and activation of the oxidative stress-sensitive transcription factor NF-
κB. In this study, we used a mouse model of AngII-induced vascular injury. The 
combination of  hyperlipidemia, specific to apoE-/- mice, and high plasma 
concentration of AngII likely elicited a medial break and dilation of abdominal aorta 
followed by infiltration of aortic adventitial tissue by lipid-laden macrophages and 
lymphocytes [63]. In our study, co-exposure to low doses of PCB 77 augmented the 
incidence and severity of AngII-induced aneurysm and lead to premature rupture 
and death. In line with our observations, Bergoeing et al. showed that cigarette 
smoke exposure induces aneurysm formation and severity after subliminal doses of 
elastase [70] . 
            Rupture of aortic aneurysms is the leading cause of death from this 
disease with a mortality rate exceeding 80% even when patients arrive in time at the 
hospital. Thus, identifying factors that could prevent this fatal outcome is of outmost 
importance. PCB 77 and AngII share some common pathological features such as 
chronic inflammation and macrophage infiltration. [72, 89, 90]. Nevertheless, the 
dioxin-like toxicant had a more pronounced effect on the atherosclerotic process 
while angiotensin is required for initiation of aneurysm formation[75].  Recent 
studies in patients with abdominal aneurysms showed that progression from 
atherosclerotic lesion to aneurysm coincides with activation of the renin angiotensin 
system[91]. We showed that mice treated with PCB 77 have higher levels of plasma 
renin, perianeurysmal adipose tissue angiotensin AT1 receptor and macrophages 
(CD68). Thus, this dioxin-like compound affects both early and late events in 
aneurysm formation.   
The fundamental mechanisms that control AAA evolution remain largely 
unknown. Studies have shown that the predominant risk factors for AAA are male 
gender, advance age, smoking and hyperlipidemia [72, 92, 93]. In the angiotensin II 
induced AAA mouse model, hypercholesterolemia is necessary for AAA formation 
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[63] and AngII has been shown to increase macrophage cholesterol 
biosynthesis[94]. Importantly, in our study, apoE-/- mice receiving AngII +PCB 77 
have a further increase in total serum cholesterol levels that associated with 
increase AAA severity. Moreover, PCB 77 treated mice had an increase in total 
body weight secondary to visceral adipocyte hypertrophy, increased visceral fat 
mass and ectopic fat deposition within the liver. Previously, we have shown that 
PCB 77 induced ectopic lipid deposition in the intraperitoneal cavity of apoE-/- mice 
that received this treatment [58] and compromised the lipid metabolism [60]. This 
obese phenotype has been coupled with high serum NEFA in mice exposed to 
AngII +PCB 77. Numerous studies have correlated these metabolic alterations with 
increased severity and mortality of AAA [65, 69, 92, 94, 95].  
           Aneurysm formation is generally regarded as an inside-out process. 
Thus, the perivascular fat would assume the role of an innocent bystander[84]. 
Nevertheless, the perivascular adipocytes appear immature, produce less anti-
inflammatory adipokine adiponectin and more IL6, IL8 [83]. Diet induced obesity 
may exacerbate and promote this adipocyte phenotype [96]. Moreover, increased 
MCP-1 secretion attracts macrophages and hypercholesterolemia stimulates AngII 
peptide synthesis, therefore maintaining a vicious circle [79, 97]. Our previous in-
vitro data demonstrates that PCB 77 induces IL6, TNFα and MCP-1 and increases 
the ratio of angiotensin to adiponectin in cultured adipocytes [58]. We now 
demonstrate in-vivo that PCB 77 induces TNFα, IL1β and Ao, proinflammatory 
cytokines that contribute to the inflammatory milieu. Aside from the positive effect 
on the inflammation we found that PCB 77 induced the expression of its cognate 
receptor AhR in the perianeurysmal adipose tissue. We propose that PCB 77 may 
mimic the effect of diet induced obesity [98] and promote perivascular inflammation. 
Furthermore, since this environmental toxicant mainly accumulates in the fat tissue, 
it will facilitate its steady-state concentration. The effect of PCB 77 on macrophage 
function may be direct or indirect through upregulation of MCP-1 and renin-
angiotensin system (RAS) [96, 98, 99].  
        In summary, we conclude that dioxin-like toxicants, like PCB 77 could 
augment abdominal aortic aneurysms (AAA) and confer a substantial healthcare 
burden in the Western world. Based on new understanding of the pathophysiology 
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of AAA, recent years provided insight into possible medical treatment options. The 
presence of AAA is currently regarded as a coronary artery disease risk equivalent. 
ACE inhibitors, statins and JNK-inhibitors were shown to have the potential to slow 
down progression. Most importantly, since cigarette smoking is the main risk factor 
for both the development and progression of AAA, smoking cessation and 
avoidance of fatty food that contain dioxin-like residues remain major goals. 
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Chapter Four  
ROLE OF THE XENOBIOTIC RECEPTOR IN MURINE COLITIS 
Synopsis 
Background.  Gene-environment interplay modulates the severity of 
Inflammatory Bowel Diseases (IBD). Tobacco smoke correlates strongly with IBD 
pathogenesis and severity and contains dioxin-like components that can activate 
the Aryl Hydrocarbon Receptor (AhR). We hypothesized that downregulation of the 
AhR pathway will ameliorate colitis in a murine model of IBD.  
Methods: Acute colitis was induced in C57BL/6 AhR null mice (AhR - /-), 
heterozygous mice (AhR – /+), and their wild type (WT) littermates. Dextran sodium 
sulfate (DSS) was administered in drinking water for 7 days followed by 3 days of 
water. Clinical and morphopathological parameters were used to compare the 
groups. Gene and protein expression of anti/ pro-inflammatory cytokines were 
measured.  
Results: After a few days of DSS exposure, AhR - /- mice died, however, AhR 
– /+ mice exhibited significantly decreased disease activity compared to WT mice. IL-
10 and adiponectin expression levels increased significantly in AhR – /+ group both 
in the serum and colon (P<0.001). Colonic macrophage infiltration was attenuated 
in the AhR – /+ group. No significant differences were noted between control WT and 
AhR – /+ on water. 
Conclusion: The AhR pathway fulfills homeostatic and inflammatory roles. 
Attenuation of the AhR receptor expression in the AhR – /+ mice, resulted in a 
protective effect during DSS-induced colitis, while lack of AhR expression in the 
AhR -/- mice exacerbated the disease conditions. Modulation of AhR activity via the 
diet, cessation of smoking or administration of AhR antagonists could be viable 
strategies for the treatment of IBD. 
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Introduction 
Inflammatory Bowel Disease (IBD) is characterized by an inappropriate 
immune response to commensal flora [100, 101]. In Western countries, 1 in 200 
patients are affected by Ulcerative Colitis (UC) or Crohn’s Disease (CD), the major 
forms of IBD and their incidence is steadily increasing [102, 103].  The causes of 
IBD are unknown and the diagnosis is based on clinical, endoscopic, radiological 
and histological criteria [104]. Relevant correlations have been made between the 
level of industrialization and genetic predispositions. Differences among familial and 
geographic clustering point toward environmental factors. In Caucasians, one of the 
strongest associations has been demonstrated between smoking and severity of the 
gut inflammation [105, 106].  Previous research showed that cigarette smoke 
contains dioxins, dioxin-like compounds [107, 108]  and other persistent agonists of 
the ligand activated Aryl hydrocarbon receptor (AhR) [109, 110].   
The AhR, plays a very important role in detoxification processes by inducing 
the transcription of a battery of xenobiotic-metabolizing enzymes, such as 
cytochrome P4501A1 (CYP4501A1) [111, 112]. Studies performed in AhR null  
mice have shown an enhanced inflammatory response to cigarette smoke or 
endotoxin, with elevated levels of tumor necrosis factor-α (TNFα)  and  interleukin-6 
(IL-6)[113]. In addition to its classical role in inducing CYP1A1 expression, the AHR 
has more recently been found to play a role in the regulation of cell cycle  [114, 
115], lipid metabolism [115], circadian rhythms [116] and   the  immune response 
[117, 118]. Although the role of the AhR in response to environmental toxicants has 
been extensively studied, its role in the gut pathophysiology is poorly described. In 
addition, AhR - /-  mice have immature hematopoietic stem cells, abnormalities in 
liver development, thymus atrophy, are prone to cancer [119-121], and exhibit a 
phenotype of enhanced responsiveness to inflammatory challenges [122]. 
Therefore, AhR seems to be crucial as a co-factor in regulation of both homeostasis 
and inflammation in the gut. Surprisingly, activation of AhR by its high affinity and 
prototypical agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),  agonist, resulted 
in altered bone marrow and thymic development, suppressed immune responses 
and low resistance to infectious diseases and cancer in mice[123-125]. Collectively, 
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these observations suggest that a low to normal activation of AhR is beneficial, 
rather than detrimental, for the protection against environmental insults representing 
an important link between environment and chronic diseases. 
      Our preliminary experiments indicated that AhR KO mice are highly 
sensitive to DSS-induced colitis. In the current study, we examined the outcome of 
DSS-induced colitis in wild type and AhR heterozygous mice. Interestingly, 
downregulation of AhR pathway in the AhR heterozygous mice was sufficient to 
ameliorate colitis in DSS treated mice. We also provide evidence that the level of 
AhR expression correlates with the profile of cytokines, adipokines and ER stress 
response. Based on our data, we propose that persistent activation of AhR, through 
environmental and endogenous ligands, promotes chronic inflammation in patients 
with IBD.     
Materials and Methods 
Animal treatments and sample collection 
Male, 3 months old C57BL/6 and AhR -/- mice (The Jackson Laboratory, Bar 
Harbor, ME), or AhR – /+ mice bred in-house to C57BL/6 mice from stock originally 
purchased from The Jackson Laboratory (n = 6 mice/group) were housed in a 
pathogen-free environment. All animals had free access to food and water. Mice 
were administered 3.5% (wt/vol) DSS (ICN Biochemical, Aurora, OH) in water for a 
week, followed by 3 days of water only. Body weight, stool consistency and rectal 
bleeding, were monitored daily.  On day ten, mice were euthanized with 
ketamine/xylazine (100/10 mg/kg i.p.) for blood and tissue harvest. The colons were 
removed and perfused with phosphate-buffered saline (PBS), at pH 7.4. Half of 
each colon was immediately immersed in an RNA stabilizing solution – RNAlater 
(Qiagen, Valencia, CA), and stored at -20°C. The other half was made in a “Swiss 
roll”, cut and fixed in 10% buffered formalin (Sigma Chemical Co., St. Louis, MO). 
All procedures were approved by the Animal Care and Use Committee at the 
University of Kentucky.  
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Analysis of mRNA gene expression levels in colonic tissue 
Total RNA was purified using MagnaPure Compact RNA Isolation Kit 
(Roche, Indianapolis, IN) according to the manufacturer’s directions. RNA was 
reverse transcribed to generate cDNA templates using the Transcription High 
Fidelity cDNA Synthesis Kit (Roche). Specific mRNA levels were quantified by 
reverse transcription-polymerase chain reaction (RT-PCR), using the iCycler (Bio-
Rad, Hercules, CA), IQ SYBR Green Supermix (Bio-Rad). Primers were designed 
using the Primer 3 software (SourceForge, Mountain View, CA).  The mRNA level of 
2 reference genes which did not vary between groups were used to normalize 
mRNA levels for test genes according to the comparative CT method also referred 
to as the 2 ─ ∆∆CT method.  The formula used was  [2─ (CT test – CT reference)] x 100%.  
Histology 
Colons fixed in formalin were then embedded in paraffin. The 5 -7 μm thick, 
serial sections were mounted on glass slides, stained with hematoxylin and eosin 
and evaluated by light microscopy for the presence of lesions. A pathologist blinded 
to the group allocation assessed the severity of colitis. 
PCNA (Proliferating Cell Nuclear Antigen) assay 
The paraffin-embedded sections were deparaffinized and treated with 
Antigen Retrieval Solution (DAKO, Carpinteria, CA) according to the manufacturer’s 
instructions. Sections were incubated in horse blocking serum for 90 min followed 
by primary antibody, overnight, at 4°C and biotinilated secondary antibody (Elite 
ABC kit, Vector, Burlingame, CA) for 2 hours. PCNA antibody was obtained from 
Novocastra (UK). The slides were subsequently counterstained with Methyl Green 
(DAKO, Carpinteria, CA). Images were obtained using an Olympus BX51 
microscope (Olympus America Inc., NY). 
Immunohistochemistry  
The 5 - 7 μm thick, serial colon sections were deparaffinized, rehydrated, and 
treated for 10 min with a citric acid-based antigen-unmasking solution (Vector 
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Laboratories, Burlingame, CA). Sections were blocked with normal goat serum (1% 
in PBS) and incubated overnight at 4°C with primary antibodies diluted (1:50) in 
blocking buffer: Primary antibody used : Angiotensin II (BGN/0856/21) - a mouse 
anti-human monoclonal antibody, Angiotensin Receptor 1 ( AT1 - 306:sc-579) - a 
rabbit  anti-human polyclonal antibody, Angiotensin Converting Enzyme (ACE - H-
170:sc-20791) - a rabbit anti-human polyclonal  antibody, (Santa Cruz 
Biotechnology, INC.). After washing, sections were incubated for 1 h with a mixture 
of Cy2-conjugated goat anti-mouse IgG or Cy3-conjugated goat anti-rabbit IgG 
(Jackson ImmunoResearch Laboratories, West Grove, PA, catalog numbers 115-
225-146 and 111-165-144). Sections were counterstained with 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Molecular Probes Invitrogen, Eugene, OR) to 
visualize nuclei, and mounted with VECTASHIELD® medium (Vector Laboratories). 
Images were obtained with an Olympus BX51 microscope, using a 20x objective. 
Image-ProPlus 5.0 software (Media Cybernetics, Inc.) was used to generate the 
composite images.  
Statistical analysis  
Data are expressed as Mean ± SEM. Data were tested for normality and 
equal variance  and analyzed using one-way analysis of variance (ANOVA) 
(GraphPad Prism 5, GraphPad Software Inc., San Diego, CA) followed by Tukey’s 
test. Body weight data were analyzed by one-way ANOVA with repeated measures 
on time. Survival percentage has been calculated using Kaplan-Meier method. 
Significance was accepted at p < 0.05. 
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Results 
DSS- induced colitis severity is decreased in AhR -/+ mice  
Preliminary experiments showed that AhR KO mice do not survive beyond 
day 7 of DSS induced colitis (Fig 4.1). Therefore, in the current study, AhR 
heterozygous and wild type mice were analyzed. There was a 50% reduction in 
AhR mRNA in colonic tissue of AhR – /+  mice (Fig 1A).  No change in the AhR 
expression was noted during colitis in either the wild type or AhR – /+ mice or water 
fed littermates.  At the end of the experiments, wild type mice lost significantly more 
weight (Fig 1B. P=0.001), and had a significant drop in the hematocrit (Fig 1C. 
P=0.002). Although the AhR pathway regulates adipocyte growth, no differences in 
body weight were noted between the control AhR – /+ and WT groups.  Postmortem 
exam revealed swollen and shortened colons in the WT mice compared to AhR –/+ 
mice exposed to DSS (Fig 4.1D p=0.01). Microscopically, colitis was mild in the 
AhR – /+ group as compared to that observed in the WT mice, which displayed 
significant mucosal ulceration, crypt abscesses and altered architecture as reflected 
in the histology score (Fig 4.1E P=0.001), and H/E colon sections (Fig 2A).  
PCNA staining revealed a significant decrease in crypt proliferative activity 
within the DSS treated WT group as compared to the AhR – /+ group (Fig 4.2B) , 
consistent with defective epithelial turnover. Furthermore, there were no significant 
differences between AhR – /+ with and without colitis and water fed WT mice. 
AhR -/+ genotype favors Th2 over Th1 type cytokine expression 
The cytokine milieu within the gut defines the outcome of both innate and 
acquired immune cells activation. We investigated the expression of classical 
Th1/Th2 cytokines documented in both DSS colitis and IBD patients [27]. Wild type 
mice exposed to DSS developed colitis that was characterized by significant 
expression of TNFα (Fig 4.3A, and Fig 4.9), p=0.001. Importantly, AhR – /+ mice 
had significantly lower baseline TNFα mRNA expression as compared to that in wild 
type mice (Fig 4.3A) and did not change during colitis. Intestinal macrophages play 
a central role in the immune response to commensal flora and become a source 
Th1 cytokines in IBD [28]. There were significantly less cells expressing the 
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macrophage marker F4/80 (Fig 4.3B) in AhR – /+ mice, both during colitis and 
normal conditions. Although the monocyte chemoattractant protein expression 
increased during colitis in AhR – /+  mice, this was significantly lower compared to 
wild type mice (Fig 4.3C), p=0.005. AhR – /+ mice had similar baseline expression 
of IL10 within the colon. Nevertheless, during DSS colitis there was significant 
upregulation of this anti-inflammatory cytokine in AhR – /+ mice (Fig 4.3D, and Fig. 
4.10) p=0.005. Secretory leukocyte protease inhibitor (SLPI) mainly expressed in 
the colon by epithelial cells is a potent inhibitor of Th1 like cytokines. We observed a 
prominent induction of SLPI gene expression in AhR – /+ (Fig 4.3E), p=0.0001, 
during DSS induced colitis. Moreover, the gene expression of SLPI during DSS 
colitis was significantly higher in AhR –/+ mice as compared to that in the wild type 
(Fig 4.3E), p=0.004. 
Th17 to Treg shift occurs during DSS-induced colitis in AhR -/+ mice 
Aside from the classical Th1/Th2 paradigm, we further investigated the 
expression of master regulators for Th17 and Treg cells during colitis. No 
differences were found under basal conditions between the AhR – /+  mice and WT 
(Fig 4.4A-C). During DSS colitis there was a significant up regulation of Treg 
specific transcription factor FOXp3 in AhR – /+  mice as compared to that in the WT 
mice (Fig 4.4A) p=0.004. In contrast the mRNA expression of Th17 specific 
transcription factor, RORγ was significantly downregulated in AhR – /+ mice relative 
to the wild type mice (Fig 4.4B), p=0.021. Consistent with the latter finding, we 
observed a significant attenuation of IL17 gene expression in AhR – /+ mice (Fig 
4.4C, and Fig 4.11), p=0.0001. 
Pro-inflammatory adipokines are decreased in AhR -/+ mice during DSS colitis 
Mesenteric adipose tissue can become a source of inflammatory mediators 
referred to as adipokines. Nevertheless these mediators can be expressed intestinal 
cells and fulfill homeostatic and inflammatory roles. Angiotensin and osteopontin are 
proinflammatory adipokines, abundantly produced in the adipose tissue as well as 
gut epithelial and lamina propria immune cells [29-31]. During postmortem collection 
of the colons, we carefully removed the adjacent fat tissue. We determined that both 
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AhR – /+  and WT C57BL/6 mice express components of the angiotensin system as 
well as osteopontin within the colon (Fig 4.5 A-E). Pharmacological blockade of 
renin-angiotensin system decreased severity of colitis in several mouse models [30, 
32].  We show that DSS exposure resulted in significant downregulation of the 
angiotensin I/II precursor, angiotensinogen (Fig 4.5A), p=0.0001. Moreover the 
mRNA expression of angiotensin converting enzyme (ACE) was significantly 
decreased (Fig 4.5B) p=0.0048 compared to the wild type group. Furthermore the 
angiotensin receptor AT1 was similarly reduced (Fig 4.5C) p=0.003, in AhR – /+ 
mice. Interestingly, there was a significant downregulation of AT1 under basal 
conditions, between the AhR -/+  mice and control WT mice (Fig 4.5C) p=0.023. 
Immunohistochemistry of colon sections from DSS exposed mice (Fig 4.5E, and Fig 
12), revealed decreased angiotensin II, ACE and AT1 receptor production in the 
AhR – /+ mice. Additionally, angiotensin II, ACE and AT1 receptor co - localized on 
the same cell population. Osteopontin, another proinflammatory adipokine, was 
significantly increased in the wild type mice during colitis (Fig 4.5D), p=0.0001. 
Anti-inflammatory adipokine, adiponectin is increased in AhR -/+ mice with colitis 
The anti-inflammatory adipokine, adiponectin is considered an exclusive 
product of adipose tissue. Here, we show that adiponectin mRNA is expressed in 
the colon (Fig 4.6A).  Next, we asked whether induction of colitis impairs 
adiponectin expression, and/or promotes a state of adiponectin resistance by 
downregulating its receptors. A significant drop in adiponectin mRNA expression 
was observed, during colitis, in wild type but not the AhR -/+ mice (Fig 4.6A), 
p=0.0006. AhR+/- mice on DSS had similar expression to AhR+/- mice on water, 
and significantly higher compared to WT group on DSS (p=0.005). Furthermore, 
adiponectin receptors (AdipoQ R1 and R2) were downregulated during DSS colitis 
in all groups (Fig 4.6 C, D). Interestingly, T-Cadherin mRNA expression, a novel 
adiponectin receptor, was significantly upregulated in AhR – /+ mice exposed to 
DSS, compared to wild type mice with colitis (Fig 4.5B), p=0.037. This receptor 
lacks a signaling domain but may serve to anchor adiponectin to cell surfaces and 
facilitate non-receptor mediated functions. Secretion of the adiponectin is controlled 
by a pair of molecular chaperones in the ER (endoplasmic reticulum), Erp44 (ER 
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protein of 44 kDa) and Ero1-Lα (ER oxidoreductase 1-Lα). Erp44 inhibits the 
secretion of adiponectin oligomers while Ero1-Lα releases adiponectin trapped by 
Erp44. AhR – /+  mice exposed to DSS had significantly lower expression of Erp44   
as compared to that in the WT mice, while Ero1-Lα mRNA expression was similar 
(Fig 4.6D, E), p=0.002. Thus the ratio of these molecular chaperones favors 
adiponectin secretion in AhR -/+ mice. 
The endoplasmic reticulum stress response is low in DSS-treated AhR+/- mice  
The development of colitis during DSS administration is associated with 
cellular stress characterized by accumulation of misfolded proteins within the 
endoplasmic reticulum (ER) in the colonic epithelium. The latter event induces a 
three-pronged response mediated by IRE1 (inositol-requiring transmembrane 
endonuclease 1), PERK (pancreatic ER kinase) and ATF6 (activating transcription 
factor 6). Under normal conditions, BIP (ER -binding protein, Grp78) sequesters 
these proteins. Increased BIP expression is a marker of ER stress. XBP1 (X-box 
binding protein 1) is part of the most evolutionarily conserved pathway downstream 
of IRE1. We observed a significant downregulation of BIP (p=0.018) and XBP1 
(p=0.002) in the AhR – /+ mice exposed to DSS as compared to the WT mice with 
colitis (Fig. 4.7). The ER stress response is coupled to the cell death program. We 
investigated the mRNA expression of two pro-apoptotic molecules: CHOP (C/EBP 
homologous protein) and Casp12 (Caspase 12). There was a significant 
downregulation of both gene targets in the AhR – /+ mice exposed to DSS (Fig 4.7). 
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Figure 4.1.  DSS-induced colitis is attenuated in AhR-/+mice. Mice were 
administered 3.5% DSS dissolved in water for 7 days followed by 3 days of water. 
Control mice received water alone for 10 days. (A) Kaplan-Meier percentage 
survival curve (B) AhR mRNA expression in the colonic tissue of AhR-/+ and WT 
mice. (C) Body weight at the end of the experiment. (D) Changes in hematocrit at 
the end of the experiment. (E) Changes in colon length. [F] Histology scores for 
AhR-/+ and WT mice with colitis. Data are expressed as mean ± SEM, n=10/group. 
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Figure 4.2. DSS-induced colitis histological severity is decreased in AhR-/+mice. (A) 
Representative photomicrographs of paraffin-embedded, H&E-stained sections of 
the colon in DSS-treated mice. [a] Colonic sections of DSS-treated AhR-/+ mice. [b] 
Water-treated AhR-/+ mice. [c] DSS-treated WT mice. [d] Water-treated WT mice. 
(B) Assessment of epithelial cell proliferative index by immuno-staining of paraffin-
embedded colon section for PCNA: [a] Colonic sections of DSS-treated AhR-/+  
mice. [b] Water-treated AhR-/+ mice. [c]  DSS - treated WT mice. [d] Water-treated 
WT mice.  
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Figure 4.3. The expression of pro-inflammatory cytokines and macrophage marker 
in AhR-/+mice. (A) TNFα, (B) F4/80 and (C) MCP1 during DSS -induced colitis in 
AhR-/+mice. Increased expression of anti-inflammatory cytokines in the colon of 
DSS - treated AhR-/+ mice. (D) IL10 and (E) SLPI. The mRNA expression levels 
were measured in whole colon tissues of mice on day 10 by real-time PCR and 
normalized to the reference gene. Data are expressed as mean ± SEM, n=10 / 
group 
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Figure 4.4. Differential expression of master regulators for Treg and Th17 cell. 
Colon of WT and AhR-/+ mice.  Increased expression of (A) FoxP3 mRNA levels and 
attenuated expression of (B) RORγ and (C) IL17 in AhR-/+ mice treated with DSS. 
The mRNA expression levels were measured in whole colon tissues of mice on day 
10 by real-time PCR and normalized to the reference gene. Data are expressed as 
mean ± SEM, n=6 / group.  
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Figure 4.5 . Proinflammatory adipokines are decreased in AhR-/+ mice. (A) 
Angiotensinogen mRNA expression. (B) ACE. (C) AT1a receptor. (D) Osteopontin. 
The mRNA expression levels were measured in whole colon tissue of mice on day 
10 by real-time PCR and normalized to the reference gene. Data are expressed as 
mean + SEM, n=6 / group. (E) Fluorescence immunohistochemistry for angiotensin 
II (green) and AT1aR (red) in AhR-/+ (a) and WT mice (b) treated with DSS. The 
panels a, and b show dual staining. 
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 Figure 4.6. Adiponectin is negatively regulated during colitis. (A) Expression of 
adiponectin in WT mice treated with DSS was significantly lower compared to AhR-
/+ mice. (B) Decreased T- Cadherin receptor expression in WT mice with colitis. (C), 
(D) Decreased adiponectin receptors in the context of low adiponectin expression 
may further impair signaling downstream of this adipokine . (E) Increased 
chaperone protein, ERP44 relative to its partner, endoplasmic reticulum 
oxidoreductin (ERO) can block the secretion of adiponectin in WT mice with colitis. 
The mRNA expression levels were measured in colon tissues of mice on day 10 by 
real-time PCR and normalized to the reference gene. Data are expressed as mean 
± SEM, n=10 / group. 
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Figure 4.7. Epithelial cellular stress is decreased in AhR-/+ mice.  Decreased mRNA 
expression of endoplasmic reticulum stress response proteins (BIP, XBP1) and 
related pro-apoptotic factors (CHOP, Casp12). mRNA expression levels were 
measured in whole colon tissues of mice on day 10 by real-time PCR and 
normalized to the reference gene. Data are expressed as mean ± SEM, n=10 / 
group. 
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Figure 4.8. Colonic TNFα protein levels are decreased in DSS treated AhR-/+ mice. 
TNFα was measured in the colon homogenate of WT and AhR-/+ mice at day 10, 
using a bead based immunoassay (Lincoplex). Data are expressed as mean ± 
SEM, n=10 / group.  
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Figure 4.9. Decreased production of IL10 protein in WT mice. IL10 was measured 
in the colon homogenate using a bead based immunoassay. Data are expressed as 
mean ± SEM, n=10 / group. 
 
 
 
 
 
 
 
 
 
66 
 
  
 
 
 
Figure 4.10. Decreased production of IL17 protein in AhR-/+ mice . IL17 was 
measured in the colon homogenate using a bead based immunoassay. Data are 
expressed as mean ± SEM, n=10/ group. 
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Figure 4.11. Colonic angiotensin converting enzyme is over expressed in WT. 
Fluorescence Immunohistochemistry for Angiotensin (green) and ACE (red) in AhR-/+
 mice treated with DSS and water (A, B) and WT mice treated with DSS and water 
(C, D). Panels on the right (a, b, c, d) show dual staining.   
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Discussion 
 
Although the precise pathogenesis of IBD still needs to be unraveled, recent 
studies have reinforced the strong association between smoking, disease severity, 
complications and resistance to treatment [106, 126]. Mahid et al. found a greater 
prevalence of IBD patients in Kentucky, a state that ranks second in the nation in 
tobacco production and first in its use [55]. Mainstream cigarette smoke contains 
high level of dioxins and dioxin-like chemicals that are known to be strong inducers 
of AhR [107, 108]. In addition to their prolonged half life, these ubiquitous 
contaminants are highly lipophilic and accumulate in the adipose tissue [58]. 
Therefore, with the increase in body weight due to the obesity pandemic, the body 
burden of dioxin-like toxins will follow exponentially. This undesired availability of 
toxicants will possibly lead to a prolonged  activation of the AhR signaling pathway 
[127] .  
Persistent activation of the AhR has been extensively researched using 
TCDD, a high affinity and highly specific AhR agonist [128].  Administration of 
TCDD to laboratory animals induces a plethora of adverse effects including immune 
dysfunction. On the other hand, TCDD exposure has been shown to induce 
inflammation by promoting tissue migration of immune cells [129, 130], and an 
increase in cytokine expression [131, 132]. Surprisingly, macrophages isolated from 
mice lacking the AhR produce higher amounts of IL-1, IL-6 and TNFα in response to 
LPS [133, 134]. Earlier studies indicated that AhR null mice develop colitis and 
rectal prolapse and have a propensity to develop colon cancer[135] .  The inferred 
conclusion from the data obtained from  either  the ligand-activated  AhR cell 
lineages or AhR null mice have underlined the physiological importance of this 
receptor in cell growth [123, 136, 137] , cell apoptosis [138, 139], and its elaborate 
cross-talk with NF-kB [38, 140], and ER stress response [141].  
To explore the association between the AhR pathway and IBD pathogenesis, 
we induced colitis in AhR - /-, AhR – /+, and AhR + /+   mice. We found that mice 
lacking the AhR, succumbed early to inflammation while the WT developed severe 
colitis. In comparison, the AhR heterozygous mice had a good clinical outcome 
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during DSS administration and presented little structural changes in intestinal 
mucosa architecture. Macrophages play an important role in the innate immune 
response to bacteria. In patients with Crohn’s disease, there is an influx of CD14+ 
macrophages within the gut, which become a rich source of TNFα [142]. Blockade 
of this proinflammatory cytokine induces disease remission in patients with IBD and 
experimental models of colitis [143-145]. We found that under basal conditions and 
during colitis, AhR – /+ mice express significantly lower levels of TNFα as compared 
to that observed in the wild type groups.  Moreover, the expression of the 
macrophage marker F4/80 was decreased in the colon of AhR – /+ mice during 
colitis.  It is increasingly acknowledged that the AhR pathway modulates a number 
of immune responses[146]. While the specific AhR-induced mechanisms that 
underlie its effects on the immune system are poorly understood, numerous genes 
activated during the immune response have been found to contain DNA recognition 
sites for the AhR/ARNT heterodimers [47, 48].   Furthermore, the AhR pathway has 
been shown to play a significant role in the development of both Th17, and Treg cells 
[147]. The pathogenic role of Th17 cells as well as defective function of T-regulatory 
cells has been found in patients with Crohn’s disease and animal models of IBD 
[148, 149]. In the current study, we show that there is significant downregulation of 
the Th17 lineage master regulator, RORγ, with a corresponding upregulation of Treg 
transcription factor Foxp3 in the colon of AhR – /+ mice during colitis. Consistent with 
these changes, we have also noted a significant decrease in the IL-17 expression 
and a corresponding increase in IL-10 expression. Thus, the level of AhR 
expression correlates with the outcome of experimental colitis and the Th17 / Treg 
balance in the colon.  
The adipokines and  cytokines secreted by adipose tissue have been 
increasingly recognized as bona-fide immune regulators[150]. Angiotensin, a 
proinflammatory adipokine is generated from angiotensinogen through the 
proteolytic activity of ACE and tissue chymases. AT1a is the main receptor that 
mediates the pro-inflammatory actions of angiotensin [151, 152]. Intestinal mucosa 
is a rich source of ACE, while macrophages express the full renin-angiotensin 
system. Increased ACE was reported in Crohn’s disease patients, while blockade of 
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the enzyme or angiotensin receptor protects mice from experimental colitis [153, 
154]. In our study, AhR wild type mice that developed colitis had high expression of 
the angiotensin system components. Furthermore, there was a significant increase 
in lamina propria cells expressing both angiotensin and AT1a. We have previously 
shown that AhR agonists induce expression of angiotensinogen and 
proinflammatory cytokines in cultured adipocytes [58]. Our current finding that AhR – 
/+ mice fail to upregulate angiotensin system during DSS colitis further implicate this 
system in AhR- mediated inflammation.  
Adiponectin, the primary adipokine with anti-inflammatory activity was 
downregulated in the wild type AhR mice that developed severe colitis, while the 
opposite was found in AhR – /+ group. We have previously demonstrated that AhR 
activation downregulates the expression of this adipokine in fat cells [58].  In the 
current study, we report that attenuated AhR expression, as in the AhR – /+ mice, 
correlates with higher adiponectin and adiponectin receptor expression during DSS 
treatment (Fig. 6). This implies that AhR may modulate the expression of key 
intracellular proteins that control adiponectin expression and function. This 
correlation might be very important since adiponectin has a protective role in 
experimental colitis as recently shown by the Nishihara group [155]. Furthermore, it 
was demonstrated that adiponectin treatment protects adiponectin KO mice from 
developing DSS-induced colitis. Interestingly, the protective effect of adiponectin 
treatment was not observed when colitis was induced using TNBS. Since the latter 
model is more dependent on T cells, one may speculate that adiponectin has a 
greater influence on innate immunity. This is also supported by the fact that T cells 
from either wild type or adiponectin KO mice  produce similar amounts of IL-6, IL-
17, TNF-α and IFNγ upon stimulation with anti CD3/CD28 [156]. In addition, 
adiponectin has been shown to induce IL-10 [157], and thus, promoting alternative 
activation of macrophages and resolution of chronic inflammation. In vitro studies 
revealed that adiponectin suppressed expression of IL-8 in the human HT-29 
epithelial cell line [56].Therefore, in our study, the increased adiponectin and 
adiponectin receptor in AhR – /+ mice may have had an important role in 
maintaining tissue homeostasis during DSS induced colitis.  
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Recent studies have shown that an increased endoplasmic reticulum stress 
response in epithelial cells promotes colitis. Importantly, mutations in XBP1, a key 
component of this response, have been associated with Crohn’s disease [158]. As 
shown in the current study, DSS-induced colitis resulted in an increase in the 
expression of ER stress markers in the wild-type mice, but a decrease in their 
expression in the AhR – /+ mice (Fig. 6). Furthermore, increased IL-10 expression in 
the latter group may have also reduced the stress response associated with colitis 
[159]. It is also possible that the ER stress response itself can facilitate AhR 
signaling and in this manner, mediates a  vicious cycle of ER stress, AhR activation 
and enhanced inflammation  during the development of colitis [160].  
Cigarette smoking is considered a risk factor for Crohn’s disease and 
protective for Ulcerative Colitis. Despite their similarities, there are unique 
phenotypic, molecular and genetic features in these disease entities. TLR-4 (Toll 
receptor 4) pathway is involved in LPS signaling and is preferentially activated in the 
colon of UC patients [161]. Recent studies in macrophages showed that AhR 
receptor can interact with NF-kB and prevent its binding to the promoter region of 
pro-inflammatory cytokines[134]. Thus, activation of NF-kB downstream of TLR 
signal can be blunted by smoke exposure. Since macrophage function appears to 
be compromised in CD[162], this protective effect of smoking would not be 
operative. The effect of AhR on T cells is ligand dependent. TCDD induces 
persistent AhR activation and Treg cells [118]. This cell population is uniquely 
increased in UC. On the other hand dietary derived, short acting ligands, such as 
FICZ (6-formylindolo, 3, 2-b-carbazole) induces Th17 differentiation [163]. The 
relative abundance of the different ligands, along with the AhR system 
polymorphisms may further modulate the response [164, 165]. In our DSS model 
AhR activation most likely occurred through dietary (i.e. FICZ) and endogenous 
ligands with similar kinetics, thus explaining the upregulation of IL-17 and RORγ. 
The increased number of colonic macrophage in wild type mice compared to AhR+/- 
seems contradictory. Nevertheless, recent in-vitro studies in macrophages 
described an ARNT independent, non-genomic pathway downstream of AhR that 
induces an inflammatory response [4]. We hypothesize that low AhR expression 
may be coupled to the classical signal that downregulates macrophage function 
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whereas increased receptor expression preferentially activate the non-genomic 
pathway and hence promotes inflammation. In the absence of AhR, as in null mice, 
the inhibitory activity of NF-kB on macrophages would be lost whereas the Th17 cell 
development would be blocked. Ultimately, both effector T cells and inflammatory 
macrophages will mediate the colitis in WT mice while in the null mice mainly the 
innate immune arm will be active. The heterozygous mice would preferentially 
activate Treg cells and blunt the macrophage response as inferred from FoxP3 
upregulation and decreased macrophages in our DSS model. 
In summary, we provide novel evidence that dysregulated expression of the 
AhR alters the outcome of colitis. The extreme phenotypes of AhR null and wild 
types groups indicate that AhR pathway fulfills both tissue homeostatic and 
inflammatory roles. Modulation of this pathway through diet, cigarette smoking 
cessation, as well as pharmacological antagonists of the AhR could be viable 
strategies for the treatment of IBD.  
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Chapter Five 
 Conclusions 
 
Environmental factors that activate the AhR influence the pathology of a 
number of disease states by altering the magnitude and duration of the 
inflammatory response [109]. The contention that activation of the AhR contributes 
to chronic inflammatory disease states is supported by observations that this 
pathway regulates a number of genes classified as proinflammatory [166]. Our 
current studies explored the role of AhR agonists and AhR pathway in two disease 
models where chronic inflammation plays an important role: aortic aneurysm and 
Inflammatory Bowel Disease. Both conditions are characterized by transmural 
inflammation that includes the adjacent adipose tissue [96, 167, 168]. Humans and 
animal studies have demonstrated that PCBs accumulate in the fat tissue [169, 
170]. Therefore, we performed our initial experiments in adipocytes. We showed 
that PCB77 induces adipocyte maturation and excessive accumulation of 
intracellular lipids. These effects occurred at low dose of AhR agonist whereas high 
doses had the opposite effect [58]. This has practical implications since most of the 
population at risk is likely to be chronically exposed to low doses. Furthermore, in 
chapters 2 and 3 we show that PCB77 increases visceral adipose tissue mass, and 
promotes ectopic fat deposition in the liver and peritoneal cavity. Importantly, AhR 
KO mice treated with PCB 77 did not gain weight. The increased visceral adipose 
tissue volume was accompanied by abnormal serum lipid profile similar  with the 
metabolic syndrome. Consistent with these observations, mice that received PCB77 
developed atherosclerosis, one 
of the early events in the 
pathogenesis of abdominal 
aortic aneurysms (AAA).  
Inflammation plays an important 
role in development of 
atherosclerotic lesions and 
aortic aneurysms [171]. It has 
Periaortic fat 
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been proposed that aortic aneurysms resemble an autoimmune process, and is 
characterized by a chronic inflammatory response to aortic wall antigens [172].  Pro-
inflammatory cytokines can be released systemically or produced locally within the 
endothelium, aortic wall, or peri-aortic fat [96, 173-176]. The atherosclerotic plaque 
itself may become a source of inflammatory mediators [176]. Moreover, circulating 
immune cells (i.e. macrophages, T cells) migrate to the site of the atherosclerotic 
and aneurismal lesions to complete a vicious circle [177, 178]. Several studies have 
addressed the importance of the cytokines in the development of human abdominal 
aneurysms [171, 179-182]. The majority of these studies compared the relative 
expression of cytokines in normal aortas, aneurismal wall and aortic atherosclerotic 
lesions without aneurysm. Compared to normal vessels, the latter two showed 
significant upregulation of: IL-1β, IL-6, IL-8, TNFα, IFNγ and MCP-1. Interestingly, 
TNFα, IFNγ and MCP-1 were significantly upregulated in patients with aortic 
aneurysms compared with those having only atheromatous lesions. Thus, these 
cytokines are more specific to the development of AAA. Overall, these findings are 
consistent with a Th1 type of inflammation [183, 184]. The increased levels of MCP-
1 also point to a strong chemotactic signal for macrophages that would promote a 
chronic inflammatory state. In a mouse model of angiotensin induced AAA, obese 
mice had higher expression of MCP-1 and macrophage infiltration in the peri-aortic 
fat tissue when compared with lean [96]. In a rat model of elastase induced 
aneurysm, early expression of MCP-1 was followed my macrophage infiltration in 
the abdominal aorta concomitant with MMP-2 mRNA upregulation and elastic fiber 
disruption [185]. Collectively, the data indicate that regardless of species and mode 
of induction, MCP-1 and macrophage infiltration are linked to the development of 
abdominal aortic aneurysms.  
Our in-vivo and in-vitro studies (chapters 2, 3) show that PCB77 increased 
expression of pro-inflammatory cytokine TNFα, chemokine KC (CXCL1), and MCP-
1 within adipocytes and perianeurysmal adipose tissue. Obesity is associated with 
migration of bone-marrow derived macrophages into the visceral adipose tissue. 
They acquire an M1 (classical activation) phenotype and secrete pro-inflammatory 
cytokines such as IL-1, IL-6 and TNFα [186, 187]. Following treatment with PCB 77, 
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we observed a significant increase in CD68+ cells in the aneurismal sac and 
surrounding fat tissue consistent with a macrophage infiltrate. The effect of PCB 77 
on macrophages could be direct or indirect through adipocyte released cytokines or 
free fatty acids [188]. On the other hand, all our experiments indicate that AhR 
pathway is involved in activation of the renin-angiotensin system.  Angiotensin II 
induces aneurysm formation in mice prone to atherosclerosis (i.e. ApoE-/-, LDL-/-). 
We show in chapter 3, that PCB 77 increases the incidence and severity of the 
aneurysms and thus appears to have an additive effect. Angiotensin II can activate 
NF-kB and promote inflammation downstream of AT1a receptor. We observed that 
PCB77 induced both angiotensin and AT1a receptor.  Nevertheless, AhR can form a 
complex with NF-kB (RelA and RelB) as well. In LPS stimulated macrophages, AhR 
forms a complex with Stat1 and NF-kB which blunts the IL-6 expression. This is in 
contrast to other studies where TCDD induces inflammatory cytokines IL-1β, IL8, or 
TNFα [189-191].     
Another important observation in our studies was downregulation of the anti-
inflammatory adipokine adiponectin ( AdipoQ) [192]. Adiponectin treatment can 
prevent development of atherosclerosis in ApoE-/- mice [193]. Moreover it 
downregulates IL-8 and TNFα production in endothelial cells, and induces IL-10 
expression in macrophages. Nevertheless, these actions that may be more relevant 
to the atherosclerotic lesion and the direct effect on aneurysm formation remain to 
be determined. 
In chapter four we focused on the role of AhR pathway in a mouse model of 
colitis. Our initial hypothesis was that signaling through AhR pathway will promote 
inflammation. Surprisingly, AhR KO mice were very susceptible to DSS induced 
colitis and succumbed within the first week. Nevertheless the observation that AhR 
negatively regulates LPS signal in macrophages [134] was consistent with our 
results. We then compared AhR heterozygous and AhR wild type mice on a 
C57BL/6 background. The latter group developed diarrhea, hematochezia,  lost 
weight significantly, an indicative of severe colitis. In contrast, the heterozygous 
group was protected. We concluded that AhR pathway plays a homeostatic role in 
the gut characterized by increased activation and inflammation in wild type 
compared to AhR-/+.  
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Inflammatory Bowel Diseases (Crohn’s disease and Ulcerative colitis) are 
characterized by chronic, relapsing inflammation resulting from a dysregulated 
cross-talk between microbiota and host cells. Crohn’s disease can involve any 
segment of the gastrointestinal tract. The disease is characterized by transmural 
inflammation which leads to stricture and/or fistula formation. Ulcerative colitis is 
limited to the colon. In contrast to Crohn’s Disease, it involves the mucosal and 
submucosal layers. [194-197]. Crohn’s disease is associated with a Th1/Th17 
response as indicated by increased expression of TNFα, IFNγ, IL-12, IL-17, and IL-
23. Furthermore, there is an acquired defect in regulatory T cell function which likely 
maintains the chronic inflammation. In Ulcerative Colitis there is an important Th2 
polarization with increased production of IL-4 and IL-13. Nevertheless, Th1 
cytokines are also involved since TNF-α blockade can induce disease remission. 
For our study, we used a DSS model of colitis. This agent induces epithelial 
damage which allows bacterial translocation into the gut tissue and subsequent 
activation of the immune system. This model has been proposed as either Crohn’s 
Disease or Ulcerative Colitis. C57BL/6 mice are CD like whereas BalbC mice are 
UC like. In all our experiments we used mice on C57BL/6 background. They 
developed transmural skip lesions in the colon, without rectal involvement as 
typically seen in CD. Moreover we have consistently seen an upregulation of 
Th1/Th17 cytokines while IL-10 was downregulated. Thus both the phenotype and 
molecular signature of this model is reminiscent of human Crohn’s disease. We 
noted an increased ratio of RORγ to FoxP3 in the colon of AhR wild type mice 
consistent with Th17 activation and Treg downregulation. 
     The very first description of Crohn’s disease showed inflammation within 
the mesenteric adipose tissue surrounding the bowel [198, 199]. Recent advances 
in metabolic and cardiovascular diseases led to paradigm shift whereby the adipose 
tissue was upgraded from an energy depot to a source of immunomodulatory 
adipokines (adipose cytokines) [200]. Adiponectin is the major anti-inflammatory 
adipokine [201, 202] whereas angiotensin II is an important pro-inflammatory factor 
[203-206]. In our DSS model of IBD (CD), development of colitis in AhR+/+ mice was 
associated with upregulation of renin-angiotensin system: angiotensinogen, 
angiotensin converting enzyme and angiotensin receptor AT1a. On the other hand, 
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both adiponectin and adiponectin receptors were downregulated. Prior studies in 
DSS model of colitis showed that blockade of renin-angiotensin system or 
adiponectin treatment protects mice from colon inflammation [155, 207]. AhR-/+ 
mice, were resistant to DSS induced colitis and had significantly lower expression of 
the renin-angiotensin components. This further reinforces the link between AhR, 
renin-angiotensin system and inflammation similar to our aortic aneurysm model in 
ApoE-/- mice.  
The favorable clinical outcome noted in AhR-/+ mice on DSS correlated with 
increased adiponectin expression. This adipokine can bind several receptors: 
adipoR1 (high affinity for the globular form of adiponectin); adipoR2 (higher affinity 
for the high molecular form) and T-Cadherin (binds hexameric adiponectin and 
higher order)[208, 209]. DSS treatment in both wild type and heterozygous mice 
promoted a state of adiponectin resistance due to adipoR1/R2 downregulation. 
Interestingly, T-Cadherin was significantly upregulated in AhR-/+ mice receiving 
DSS. The exact function of this receptor remains elusive since it lacks the signaling 
domain and likely acts as a co-receptor. It has been proposed that T-Cadherin 
exerts cardio protective effects by regulating smooth muscle and angiogenesis 
following hypoxic injury [209]. These findings are relevant for Crohn’s Disease and 
atherosclerosis since smooth muscle hyperplasia and neo-vascularization 
contributes to stricture formation. [209-211].  
 Inflammation is linked to hypoxia and cellular stress [212]. Gut epithelial 
cells secrete large amounts of protein and therefore are prone to ER stress. 
Deficiency or mutation of XBP1 (regulator of ER stress response) promotes gut 
inflammation in mice and Crohn’s Disease, respectively [213]. In chapter 4 we show 
that development of DSS colitis in wild type is accompanied by upregulation of ER 
stress response markers BIP and XBP1. Moreover, increased CHOP-10 and 
Caspase 12 indicate associated mitochondrial stress and apoptosis. Staining for 
PCNA (proliferating nuclear antigen) in the gut indicated a decrease in epithelial cell 
proliferation consistent with increased death of intestinal crypt cells. It is worth 
noting that the ER chaperone protein that blocks cellular export of adiponectin, 
Erp44, was upregulated in the AhR wild type group. Moreover CHOP-10 has been 
shown to block adiponectin gene expression induced by uncoupling protein-2 
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(UCP2-mitochondrial membrane transporter) by interfering with the CEBP 
(CCAAT/enhancer binding protein-binding) binding at promoter region [214]. 
Increased CHOP-10 as well as activation of the renin-angiotensin system in AhR 
wild type mice can also lead to oxidative stress and further aggravate 
inflammation[99]. Downregulation of AhR receptor in heterozygous mice was 
sufficient to prevent all these pathological processes.  
 In summary, we provide evidence that AhR ligands and AhR pathway 
promotes Th1/Th17 inflammation in distinct animal models and mouse strains. 
Furthermore it regulates the balance between major pro/anti-inflammatory 
adipokines which bridge immunity and metabolism in both immune and non-immune 
cells. Ultimately, the AhR pathway alters key organelle function responsible for cell 
homeostasis. 
 
Future Directions 
             The current studies underlie the role of AhR pathway in disease models 
where inflammation plays a significant role. In our murine model of Inflammatory 
Bowel Disease, we correlated the AhR expression with the cytokine profile and 
clinical outcome. We would like to gain further insight with respect to the function of 
AhR in specific cell types. Recent studies have characterized the role of this 
conserved pathway in the generation of Th17 and Treg cells [118].  
             Our future studies will focus on macrophage function. AhR pathway can 
either depress or augment the function of these innate immune cells through 
classical and non-genomic pathways.  DSS colitis model will be recapitulated in wild 
type mice chimeric whose macrophages does not express the AhR receptor. We 
will explore the effect of relevant ligands, TCDD, PCB 77 and FICZ (a Tryptophan 
metabolite) in the presence or absence of a specific flavonoid antagonist.  The in 
vivo studies will be complemented by mechanistic studies that assess the role in 
AhR in TLR signaling as well as the  crosstalk between macrophages, intes- 
tinal epithelial cells and adipocytes. Lastly, we will examine the AhR pathway in 
lamina propria mononuclear cells from patients with Inflammatory Disease.  
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